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Adequate fl uid loading before 
installation of Pneumoperithoneum, 
together with prevention of blood 
pooling with anti-thrombosis stockings 
and adjustment of the position, 
adequate ventilation with the aim 
to minimize elevated intrathoracic 
pressures, high dose of sufentanil and 
adequate depth of anaesthesia results 
in the prevention of the hemodynamic 
and renal compromise encountered 
due to elevated intra-abdominal 
pressure, during laparoscopic donor 
nephrectomy. 
Moreover, the differences in stress 
response between open donor 
nephrectomy and laparoscopic donor 
nephrectomy have disappeared with 
this regimen. The use of propofol 
anaesthesia and the addition of 
epidural analgesia further reduced 
the stress response and provided a 
faster and qualitatively better direct 
postoperative recovery.
In conclusion, the work presented in 
this thesis shows that the anaesthetist 
is able to improve the outcome for the 
donor patient, as well as for the donor 
kidney.
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Introduction
Background
The kidney is a vital organ that may be involved in a great variety of diseases that can finally 
result in renal failure. Kidney replacement therapy consists of dialysis or kidney transplantation. 
Haemodialysis and peritoneal dialysis facilitate long-term survival of patients with end-stage renal 
disease and may bridge patients to kidney transplantation. However, dialysis has a substantial negative 
impact on the quality of life and is associated with an increased morbidity and mortality rate as 
compared to renal transplantation. 
As early as the 18th century, researchers began to explore organ transplantation in animals and 
humans. A milestone was reached in 1954 when Dr. Joseph E. Murray, performed the first successful 
kidney transplantation. His team avoided the risk of graft rejection by using a genetically identical twin 
donor 1. Thereafter, important medical breakthroughs, such as the introduction of immunosuppressant 
drugs, have legitimised the transplantation of a larger number of organs with a successful long-term 
survival for the recipients. The most notable development in this area was Jean Borel’s discovery of an 
immunosuppressant drug, called Cyclosporine, in the mid-1970s 2. 
The patients with end-stage renal disease are at risk for cardiac complications because of their 
underlying disease 3, 4. A successful renal transplant reduces mortality rate (annual death rate per 100 
patient years) by 40% to 60% when compared to patients who continue dialysis 5. 
In the Netherlands, the first kidney transplantation was performed in 1966 and, up until today, 
more than 14,500 kidney transplantations have been performed. In our country there are eight 
kidney transplantation centres, which performed about 650 transplantations in year 2006. Of these 
transplants, 274 were achieved using living donors (Figure 1.1). Nowadays 1,084 dialysis patients are still 
on the waiting list for transplantation. The mean waiting time for patients who are already screened 
and appointed for kidney transplantation has increased to 4 years (it is important to realize that only 
patients who started dialysis are considered for this list). The number of Dutch people depending on 
dialysis is 5,600 and this number is increasing every day 6.
Figure 1.1 
Kidney transplantation in The Netherlands 1966 - 2006
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Because kidney donation is still the ultimate treatment for end-stage kidney failure, we are in 
desperate need for donors. Therefore, many centres have now implemented a living donation program, 
encouraging spouses and family members to donate their kidney. Currently, at the Erasmus MC 
Rotterdam more than half of all donated kidneys are from a living donor, and the number of unrelated 
living donors is increasing. Moreover, new initiatives like the “cross-over donation” program are 
stimulated to help patients awaiting kidney transplantation. 
Living kidney donors
In general, living donors are healthy and classified as American Society of Anaesthesiologists 
(ASA) grade I or II. One of the major concerns of living organ donation is the potential to cause harm 
to healthy individuals who undergo surgery for purely altruistic reasons. Morbidity after living kidney 
donation is low; Matas et al. (2003) reported two donor deaths and one donor who has remained 
in a persistent vegetative state in a series of 10,828 living kidney donations 7. Beside mortality and 
morbidity, quality of life after organ donation is of great concern 8-10. It is important that the benefits 
of living kidney donation outweigh the risk associated with the donation and transplantation of a living 
donor organ 11. 
Organ donation from living donors has significant advantages over organ donation from 
deceased donors. The overall 3-year graft survival rate after deceased donor kidney transplant is 
>70% and after living donation >80% 12. Obviously, a number of advantages can be mentioned that 
are responsible for the improved outcome. First, the procedure can be planned on an elective basis, 
providing the opportunity to optimise the conditions around the transplantation. Secondly, the cold 
ischemia time of the organ can be reduced significantly with living donation as compared with post-
mortal donation. Thirdly, the living donors are hemodynamically stable. Fourthly, the time spent on the 
waiting list can be reduced significantly. Planning transplantation in an earlier stage of the disease can 
reduce the increase in morbidity and mortality of patients with end-stage renal disease. In a living donor 
program there is a tendency towards earlier transplantation, even as early as in the pre-dialysis period 
of the kidney patient, the so called “pre-emptive” transplantation. Finally, due to the above mentioned 
factors graft survival of kidneys coming from living donors is almost double that of kidneys from 
deceased donors.
The laparoscopic donor nephrectomy 
Traditionally the surgical approach for living donor nephrectomy was performed through a 
subcostal lateral incision, later the minimal-incision nephrectomy was adapted in our institution 13.  
Now, laparoscopic donor nephrectomy (LDN) has become the method of choice to procure kidneys from 
living donors. 
LDN is performed in lateral nephrectomy position by flexing the operation table to gain maximum 
access between the iliac crest and the ribs (Figure 1.2). Pneumoperitoneum (PP) is established by 
insufflation of carbon dioxide (CO2) with an abdominal pressure of 12 mmHg. A video endoscope and 
three to four trocars are inserted. The kidney is freed from adjacent attachments and structures, after 
which the renal vein, the renal artery and later the urethra are identified and dissected. The left gonadal, 
lumbar and adrenal veins are clipped and divided, and the adrenal gland is released from the medial 
superior aspect of the renal capsule. A suprapubic incision is made through which an extraction device is 
inserted. Then the urethra, renal vein and artery (in this specific order) are clipped and divided; hereafter 
the kidney is placed in the extraction device and extracted via the suprapubic incision. Immediately  
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after the extraction the kidney is perfused with a cold preservation fluid. 
LDN has become popular mainly because of the reduced procedure-related morbidity, shorter 
convalescence period, better cosmetic result and a superior quality of life compared with open surgery 
10,14-22. There are indications that these advances have increased the amount of living kidney donors 
and the willingness to donate. Kuo et al. reported that 47% of donors donated solely because of the 
availability of the LDN procedure 23.
Although LDN is beneficial to the donor, there are concerns about the transient function 
deterioration of the donor graft (called delayed graft function), compared to after the traditional open 
procedure. The creatinine concentration of recipients who received a kidney procured with the LDN 
procedure, decreases slower in the first weeks after transplantation compared to the open procedure 
21,24,25. Accordingly, the creatinine concentration of the donor with the LDN procedure is higher the first 
weeks after kidney donation 26.
Laparoscopic living donor nephrectomy for renal transplantation demands not only an 
operation that is safe and preferable for the donor but must also deliver a functionally intact kidney, 
providing graft function, comparable to open donor nephrectomy (ODN). It is supposed that CO2 
pneumoperitoneum (CO2PP), necessary to create a working space for the surgeon, is the incrementing 
factor related to delayed graft function 26-28. Since even moderate graft dysfunction can have a 
negative impact on graft rejection and long-term graft survival, it is of importance to minimize delayed 
graft function 29,30. Thus, this should already start with optimisation of the donor kidney in the donor 
during the procedure of procurement. 
The causes and exact mechanisms of the altered hemodynamic parameters, renal blood flow and 
reduced urine output during LDN, and delayed graft function, after LDN are probably multifactorial. 
There is an ongoing debate over the causes of these induced changes during CO2PP. Various 
mechanisms, such as venous compression caused by elevated IAP (with compression of abdominal 
vasculature and organs), and the pharmacological action of the absorbed CO2, as well as activation of 
the sympathetic and neuro-humoral factors have all been suggested to explain these transient adverse 
renal effects 27,31-41. Therefore, an understanding of the pathophysiologic consequences of increased 
intra-abdominal pressure (IAP) and elevated CO2 is important. This is summarised in Figure 1.3. 
The hemodynamic changes due to CO2PP consist of an increase in systemic vascular resistance 
(SVR) up to 65%, and a 20–59% decrease in cardiac output 42,43. The decline in cardiac output  
parallels the decrease in venous return; the last is confirmed by a reduction in left ventricular end-
diastolic volume and low atrial natriuretic peptide (ANP) concentrations. Cardiac filling pressures, 
however, rise during peritoneal insufflation. The increased intra-thoracic pressure associated with PP 
explains the paradoxical increase of cardiac pressure 44. The increase in (SVR) with subsequent elevated 
mean arterial pressure (MAP) observed during CO2PP cannot only be explained by mechanical 
compression. CO2PP is associated with activation of endocrine vasoactive factors such as  
Figure 1.2
Lateral nephrectomy position and location of trocar ports
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catecholamines, vasopressin, and renin-angiotensin-aldosterone-system, which probably contribute to 
the rise in SVR 43,45-47.
In addition, CO2PP causes a decrease in renal blood flow (RBF) up to 75% of baseline values, with 
subsequent temporary renal ischemia 27,38,40,41,46,48,49, which overall results in extra induction of acute 
tubular necrosis (ATN) 37,40,41,46,49-54. Glomerular filtration rate (GFR) and urine output reduction can be 
up to 50%, despite well-maintained arterial blood pressure 28,37,40,41,50,51,53-59. Onset of tubular damage 
usually occurs within 25 minutes of ischemia as the microvilli of the proximal tubular cell brush borders 
begin to change. 
With every surgical procedure a certain degree of ATN occurs. The kind of surgical procedure, the 
baseline clinical condition of the patient, the anaesthetic management and the duration of the procedure, 
are all variables which play a role in the occurrence of ATN 60. During LDN, which lasts around 220 
minutes, the pathophysiologic situation of elevated IAP leaves abundant time for ATN to evolve. 
Figure 1.3
Schematic representation of the different mechanisms leading to decreased stroke volume, renal 
blood flow, glomerular filtration rate and urine output, and elevated MAP during living laparoscopic 
donor nephrectomy with CO2PP
IAP:  intra-abdominal pressure
SV:  stroke volume
MAP:  mean arterial pressure
RBF:  renal blood flow
ATN:  acute tubular necrosis
UO: urine output
GFR: glomerular filtration rate
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Fluid regime 
Lateral nephrectomy position and PP, necessary for LDN, introduces relative hypovolemia. 
This position is known for its negative hemodynamic compromise, because of venous pooling in 
legs and upper body 61. The decrease in cardiac output and increase in SVR during PP is affected by 
the patient’s circulating volume before the induction of CO2PP. The reduction in venous return and 
cardiac output can be attenuated: by fluid loading, tilting the patient to a slight head-down position, 
or by preventing pooling of blood with an intermittent sequential pneumatic compression device or 
by using anti-thrombosis stockings. The initial response to a contracted extracellular fluid volume is a 
decrease in RBF, the GFR and the filtered solute load. The presence of a low circulating blood volume 
leads to a series of vasoconstrictor, salt-retaining neuro-humoral systems being activated, i.e. the 
sympathoadrenal system, renin, angiotensin, aldosterone, and vasopressin. 
In an animal model, London et al. have shown that PP resulted in a decrease in RBF during 
normal fluid management, whereas RBF did not decrease if volume expansion was given 27. From 
these results, it has been advocated to use vigorous hydration up to 2 l.-1h of crystalloids during LDN in 
patients 18,19,62-64. However, it was shown that this vigorous hydration could not prevent the impaired 
creatinine clearance as observed after LDN 19,27,65,66. Biancofiore et al. studied the effect of volume 
loading on graft function with a crystalloid infusion starting the night before surgery. In their study 
early graft function did not differ between ODN and LDN. However, with their regime, serum creatinine 
still declined earlier in those recipients receiving kidneys from ODN compared to the LDN procedure 67. 
While under-hydration may contribute to renal dysfunction, perioperative fluid excess can cause 
problems, such as pulmonary oedema, ileus and cardiac failure, as well as impaired wound healing. 
We hypothesized that volume loading after establishment of PP is too late in order to 
counterbalance the collapsed venal system. The goal is to compensate hypovolemia before PP is 
started; therefore, we designed a new fluid regimen with pre-hydration together with a bolus of colloids 
given just before the induction of PP. After prehydration, a relatively restrictive fluid regime can then 
be used during LDN, which may reduce the risk of fluid overloading, especially because during IAP 
elevation, urine output is diminished. In contrast with Biancofiore et al., we used colloids as part of the 
pre-emptive fluid loading 67.
Stress response
Surgical procedures are associated with complex stress responses, mediated by neuroendocrine, 
immunologic and metabolic alterations, which are related to the magnitude of the inflicted injury 68,69. 
Significant elevations are observed for catecholamines, cortisol, growth hormone, and anti-diuretic 
hormone (now called arginin vasopressin, AVP), due to surgical stress. Surgical stress and anaesthesia 
can affect renal function and body fluid regulation indirectly (as a reflection of overall circulatory 
responses) as well as directly 70. The function of the kidney is modified directly by efferent sympathetic 
stimulation and/or circulating catecholamines and renin-angiotensin system (RAAS) via the receptors 
in the kidney. The vasoconstriction induced by these hormones might result in renal ischemia, with 
subsequent ATN 68. Attenuating intra-operative stress is a key factor in improving general but also renal 
function outcome 71,72. 
LDN is associated with a shorter and less intense recovery phase for the donor compared to 
ODN 10,22,73. However, despite the improved conditions for recovery, the stress response is still shown to 
be significant 74,75.Catecholamines, cortisol, RAAS, and especially AVP are all released during PP. The 
increase in SVR and the reduction in urine output during laparoscopic interventions are considered to 
be mediated by these neuro-humoral factors 44. 
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Several studies have reported elevated AVP levels during increased IAP 47,54,76-79. AVP regulation 
is influenced by several mechanisms, e.g. osmotic receptors in the hypothalamus, pressure receptors in 
the atria (via ANP) and lung vessels, and high pressure receptors in the carotid sinus 80,81. CO2 and  
mechanical stimulation of peritoneal receptors also stimulates AVP release 82. AVP is a potent 
vasopressor even at normal physiologic concentrations and promotes water retention and the 
production of concentrated urine by direct action on the kidney 83,84. 
Pneumoperitoneum results also in stimulation of the RAAS, mainly because of the reduced RBF 
due to the elevated IAP and as a result of increased sympathetic efferent activation 39,43,78. Renin is 
secreted as a reaction on a decrease in circulating blood volume from the juxtaglomerular cells of the 
kidney and stimulates the production of angiotensin II and aldosterone, which in turn leads to elevated 
MAP and sodium and water resorption from the distal tubules in the kidney 68,85.
Surgical stress itself increases plasma epinephrine and norepinephrine concentrations.  
Some publications report a higher increase during laparoscopic procedures compared to open 
procedures 81,86,87. Epinephrine inevitably rises more during the procedure of LDN (which implicates 
handling of the adrenal gland, which is located next to the kidney) in comparison to other laparoscopic 
procedures. 
The different hormones interact on different levels, cathecolamine release activates RAAS, 
AVP decreases RAAS activity, and ANP interacts with AVP 88. RAAS, AVP and ANP changes can be 
prevented or modified by maintenance of normal or increased intravascular volume. Cathecholamine 
release can be prevented with high dosage of morphometica 89,90. 
An increase in all the above-mentioned plasma hormones could be the result of reduced renal 
clearance, which is known to be reduced during PP 91. 
Stress response during laparoscopic procedures in supine position (such as cholecystectomy) is 
moderate 69, whereas stress response in lateral nephrectomy position, in which donor nephrectomy is 
conducted, is significant (Table 1.1) 56,74-76. For kidney donation, where preservation of kidney function 
is of paramount importance, these physiologic changes are undesirable. In literature we found one 
study that in our view had taken most of the necessary precautions to counteract biasing factors when 
comparing hemodynamic parameters and neuroendocrine release. Lentschener et al. 2001, described 
a strict protocol for anaesthesia and fluid therapy, and found that during gynecological laparoscopic 
surgery, intra-operative hemodynamic and neuroendocrine changes did not occur, provided that 
normovolemia, adequate depth of anaesthesia, and high plasma levels of opiates were maintained 92. 
We hypothesized that if we would be able to alleviate the hormonal release associated with 
surgical stress and IAP elevation during the LDN procedure, this would have its effects on the 
hemodynamic compromise and on renal function.  Therefore, we choose for administration of high 
dosage of morphometica, sufficient intravascular volume, and mechanical ventilation with a minimum 
of positive pressure. To study the mechanism and relation with renal function of elevated IAP in relation 
with hormone release and hemodynamics we evaluated the hormonal release in ODN and LDN. 
Choice of anaesthetics may influence RBF, not only directly, but also by producing changes 
in cardiovascular function and in neuroendocrine activity. Propofol anaesthesia has been shown to 
attenuate surgical stress-induced adverse immune neuroendocrine hormone release better than other 
types of anaesthesia 89,93-100. In addition some data suggest that the anti-oxidant action of propofol 
might be associated with a more favourable metabolic and immune responses 93,97.  In addition 
oxidative stress is likely to contribute to the impairment of renal function after PP 102. Therefore we  
compared our standard isoflurane anaesthesia for the donor kidney procedures with propofol 
anaesthesia with regard to stress response during LDN and ODN procedures.
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Epidural analgesia 
The successful development of local anaesthesia began in the late 19th century. In abdominal 
surgery, thoracic epidural anaesthesia/analgesia (TEA) with local anaesthetic agents attenuates the 
stress response to surgery and improves postoperative outcome via beneficial effects on organ function 
68,72,103-108. Furthermore, transient thoracic sympathicolysis by TEA has been suggested to offer 
protective cardiac, pulmonary as well as positive immunologic and coagulation properties and thus 
decreases postoperative morbidity and mortality 105,109. 
Patients treated with TEA have excellent pain relief, a prerequisite for accelerated recovery  
from surgery, and the patients experience better health-related quality of life. 
Regional anaesthetics and the kidneys interact in a complex manner that varies according to 
the underlying cardiovascular, renal and fluid status of the patient 110. After neuraxial block-induced 
sympathicolysis, total SVR decreases around 15% to 18% in normovolemic healthy patients.  
This vasodilatation can be easily augmented with supplemental intravenous fluids. 
Spinal cord segments T4 through L1 contribute to the sympathetic innervation of the renal 
vasculature, which is innervated through sympathetic fibres from the celiac and renal plexus 111,112. 
Regional anaesthesia above this level reduces sympathetic tone to the kidney and makes RBF and 
filtration directly dependent on perfusion pressure during sympathicolysis; consequently, RBF and GFR 
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Table 1.1
Hormone levels, comparing laparoscopic versus open surgery, or retroperitoneal surgery in lateral 
nephrectomy position, derived from literature
All hormone concentrations are recalculated to the same units as used in this thesis. 
Hormone concentration at time 1 is the control. This is not taken at the same moment in all articles, in our studies they are 
taken after induction of anaesthesia, but before intubation. Time 2 is when the operation is in proceeding, in our study this 
is after 2 hours of PP installation. The data from the literature are derived as much as possible around this duration.
* data are derived from figures, ≠ Lateral decubitus position, ø Trendelenburg 
LDN; laparoscopic donor nephrectomy, ODN; open donor nephrectomy, Prop; propofol, Iso; isoflurane. PIP; positive 
inspiratory pressure.
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directly depend on MAP and intravascular volume 112,113. Provided that flow is maintained and perfusion 
pressure does not fall below the autoregulation range during epidural anaesthesia, there is little change 
in GFR or renal vascular resistance 114. 
Pneumoperitoneum created during LDN negatively affects renal hemodynamics through renal 
vein compression and activation of the neuro-humoral stress response. This is why we consider a stress-
free procedure during the procurement of a living donor kidney essential; to achieve that we used a 
relatively high dosage of sufentanil. However, the use of a high dosage of sufentanil has some side 
effects, like slow recovery. Inhibition of stress responses is known to be greatest with neural blockade 
mediated by local anaesthetics; in addition this technique offers several other advantages 72. Therefore 
we implemented this technique in our research.
Peri-operative protocol 
Considering all the above-mentioned processes that potentially compromise the donor and the 
procured kidney, a protocol for peri-operative management of LDN was developed, that would ensure 
optimal function of the donor kidney. A comparison of the different components of the new and the 
previously used peri-operative protocol are shown in Table 1.2. In short, the new protocol addresses the 
following items: prevention of preload reduction, prevention of elevated CO2 and of ventilation-induced 
elevated intrathoracic pressures, and prevention of stress-induced hormonal release.   
In order to compare the effects of the various interventions, extra per-operative monitoring of 
Old New
Stockings Not Compressing stockings
Positioning Lateral nephrectomy position Adapted lateral nephrectomy 
position
Preoperative fluid loading Not Overnight 
Prehydration Not 3 ml.IBW-kg-1.h-1, eleven hours+ 
colloids before IAP elevation
Intra operative Crystalloids 16 ml.kg-1.h-1 13 ml.IBW-kg-1.h-1
Total colloids 1000 ml 950 ml
Ventilation mode IPPV PSV
Positive pressure Mean PIP 30 kPa Mean PIP 25 kPa
Sufentanil Mean 45 µg Mean 120 µg
Monitored guided titration of 
anaesthesia 
Not BIS mean 47
Epidural analgesia Not TEA with Marcaine-sufentanil 
IPPV inspiratory positive pressure ventilation
PCV pressure controlled ventilation
BIS bispectral index
TEA thoracic epidural anaesthesia/analgesia
Table 1.2 
The old and new protocol
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patients was mandatory. Because it was the intention to perform these studies with a minimal burden to 
the donors we used non-invasive techniques. 
The BIS monitor (bispectral index monitor; Aspect Medical Systems, Newton, MA, USA) was used 
to measure depth of anaesthesia. An esophageal Doppler probe (HemoSonic 100; Arrow International, 
Reading, PA, USA) was used to measure stroke volume (SV) and left ventricular ejection time (LVET), 
which is a parameter for preload. The NICO monitor (Novametrix; Medical Systems, Wallingford, CT, 
USA) was used to measure CO2 production per minute (VCO2). 
All three techniques have been extensively validated and have been used in previous studies in 
the field of anaesthesiology.
Outline of this thesis
In chapter 2 we performed a retrospective study comparing long-term kidney function in donors 
and recipients after laparoscopic versus open donor nephrectomy. Parallel to this study, a literature 
search was performed to develop the new peri-operative protocol for the LDN and ODN procedure. 
In chapter 3, two novel fluid regimens were evaluated and compared to the previous used fluid 
regimen. The most optimal intravenous fluid therapy was used in the studies presented in the following 
chapters. To improve knowledge of the pathophysiologic processes and to answer the question what 
is responsible for the reduced cardiac output and elevated MAP during LDN, we performed the study 
described in chapter 4. In chapter 5 we evaluated whether the previously found increase in Delayed 
graft function in the LDN group compared to the ODN group was abrogated with this novel fluid 
regimen, and possible side effects of this regimen were studied. Since it is not clear from the literature 
whether previously described differences in stress response between ODN and LDN were due to the 
surgical procedure or to other factors, we performed the study described in chapter 6. In this chapter 
the stress response due to the surgical procedure (ODN and LDN) and choice of anaesthetic drug 
(propofol versus isoflurane) were compared. In chapter 7 we studied whether epidural analgesia would 
improve patient recovery and satisfaction, without impairing the beneficial effects seen with the peri-
operative protocol that used high dosage sufentanil. 
Finally, in chapter 8 the stress response was investigated in relation to high dosage of opioids 
and epidural analgesia during LDN.
Aims of this thesis 
The aim of the clinical studies described in this thesis was to develop and validate an anaesthesia 
and peri-operative care regimen, which prevents the deterioration of donor kidney function seen 
after LDN. We developed a protocol that focused on optimal hemodynamic function and low level of 
preoperative stress. Using this protocol as a basis, we searched for additional optimalization of outcome 
of the donor and donor kidney function. Secondly, the pathophysiological processes during LDN are 
studied.
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Abstract
Background: Pneumoperitoneum, as used in laparoscopic donor nephrectomy (LDN), may result 
in negative effects on renal function in donor and recipient. This study compares long-term serum 
creatinine in donor and recipient after laparoscopic and open donor nephrectomy (ODN). 
Methods: A retrospective analysis of 120 LDN and 100 ODN donors and their recipients was 
performed. Serum creatinine of donor and recipient was recorded and analyzed. The follow-up period 
post-transplantation was 3 years. 
Results: Serum creatinine in the recipients was significantly higher in the LDN groups the first 
week after transplantation. Serum creatinine in the donor was significantly higher in the LDN group at 
1 day, 3 months, and 1 year posttransplant. Finally, creatinine levels remained 40% higher compared to 
preoperative values in both donor groups. 
Conclusion: LDN results in higher short-term serum creatinine levels in donor and recipient. 
Long-term serum creatinine levels were comparable after LDN or ODN in donor and recipient.
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Introduction 
The therapy of choice for end-stage renal failure is kidney transplantation. Unfortunately, the 
number of cadaveric kidneys required for transplantation is exceeding the number of available kidneys. 
The use of kidneys from living donors might reduce the shortage of donor kidneys. Living (un)related 
donor kidney transplantation is associated with advantages such as reduced waiting-list period, elective 
nature of the operation and better graft and patient survival compared to cadaveric kidney donation 1. 
Open donor nephrectomy (ODN) is associated with a mortality of 0.03% and considerable morbidity 2. 
In order to reduce morbidity and potentially increase the number of living donors, various alternative 
techniques were introduced. Ratner et al. performed the first laparoscopic donor nephrectomy 
(LDN) in 1995 3. Several studies show a reduction in hospital stay, pain and return to work comparing 
laparoscopic to open donor nephrectomy 4-8. Other techniques currently applied are thehand-assisted 
and retroperitoneal approach. 
Establishing a pneumoperitoneum is necessary when performing a transperitoneal laparoscopic 
donor nephrectomy to provide sufficient working space and overview of the operating area to the 
surgeon. This pneumoperitoneum is, however, accompanied with important negative hemodynamic 
effects. Intra-abdominal pressure due to gas insufflation results in decreased renal flow and subsequent 
renal ischemia in the graft and the remaining kidney in the donor 9. The impact of pneumoperitoneum on 
the kidney function in donor and recipient remains controversial. Some studies show a decreased short-
term graft function in recipients of laparoscopically procured kidneys 10,11, whereas other studies show no 
difference 12-14. 
Studies investigating long-term renal function in kidney donors after open donornephrectomy 
show a deterioration in renal function of about 30% 2,15. Considering the potentially increased renal 
ischemia during laparoscopic donor nephrectomy compared to open kidney donation, we were interested 
in determining whether long term serum creatinine would be significantly higher after laparoscopic 
donor nephrectomy compared to open donor nephrectomy in both the donor and the recipient.
Patients and methods
A retrospective analysis of all living (un)related kidney donors and their recipients, operated 
between 04-01-1994 and 12-03-2002, was performed. In this period, a total of 220 donor nephrectomies 
were carried out; 120 were laparoscopic, of which eight were hand-assisted (16). All removed kidneys 
were transplanted. 
Because the first LDN at our institute was performed in December 1997, the follow-up period of 
the LDN group was shorter than that of the ODN group. Analysis was performed until 3 years follow-up 
for both groups. 
 Data from donors were collected from medical records and consisted of age, sex, and operating 
technique. Serum creatinine levels were available preoperatively and on days 1, 2, 21, 90, 365, 730, and 
1095 postoperatively. These serum creatinine levels were statistically analyzed as discussed below. Data 
collected from recipients consisted of age and sex. Serum creatinine levels were available preoperatively 
and on days 1, 2, 3, 4, 5, 7, 14, 28, 180, 365, 730, and 1095.
Statistics
Statistical analysis was performed using the SPSS 10.0 (SPSS, Chicago, IL) statistical software 
package on an intention-to-treat basis. Analysis of serum creatinine levels of donor and recipient was 
done after log-transformation to approximate normal distribution. Repeated measurements ANOVA 
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 LDN (122) ODN (100) p-value
Donor
Gender
Male 56 (47%) 43 (43%) 0.68
Female 64 (53%) 57 (57%)
Age (years) 47 (20-76) 48 (20-77) 0.70
Body mass index 25.5 (17-35) 25.8 (16-37) 0.76
Operating time (min) 236 (105-420) 157 (75-310) < 0.001
Warm ischemia time (min) 7.7 (2-17) #
Recipient
Gender
Male 74 (62%) 52 (52%) 0.15
Female 46 (38%) 48 (48%)
Age (years) 45 (16-73) 40 (18-71) 0.002
Origin donor
Related 68% 88% 0.001
Un-related 32% 12%  
using the PROCMIXED procedure from SAS showed that the differences of donors and recipients 
depended on the day for serum creatinine levels. Therefore, a univariate analysis of variance was 
performed per day. Preoperative serum creatinine levels were determined as baseline values and 
analyzed as covariate into the univariate analysis. Using regression analysis, we adjusted for differences 
between the two groups (age and origin). 
Analysis of donor and recipient age was done using the Mann-Whitney test. Categorical data 
such as sex and origin were reported as absolute numbers of patients and/or percentages and were 
compared using the chi-square test.
A p value of 0.05 was considered to be statistically significant.
Results
There were no significant differences between LDN and ODN donor-groups for age and sex 
(Table 2.1). Operating times were significantly longer in the LDN group (Table 2.1).Comparing log serum 
creatinine, LDN donors had significantly higher serum creatinine levels on postoperative day 1  
(p < 0.034), day 90 (p < 0.008) and 1 year (p < 0.031) compared to ODN donors (Fig. 2.1). In both groups 
serum creatinine remained approximately 40% higher than preoperative values (Fig. 2.2). 
In recipients, sex was not significantly different between the ODN and LDN groups. The LDN 
recipients, however, were significantly older than the ODN group. Also, the percentage of living 
unrelated donations was significantly
higher in the LDN recipients. With regard to log serum creatinine, we found significantly higher 
values in recipients of LDN kidneys compared to ODN kidneys in the first week posttransplant (Fig. 2.3).
Table 2.1.
Donor and recipients characteristics are given as number of patients (percentage) or mean (range).
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Donor and recipients characteristics are given as number of patients (percentage) or mean (range).
Figure 2.1. 
Geometric mean of serum creatinine (µmol/L) with 95% CI of living kidney donors in time 
(open squares, LDN; closed triangles, ODN). *p < 0.05 after correction for the difference in baseline values.
Figure 2.2. 
Geometric mean of serum creatinine (µmol/L) with 95% CI of recipients in time 
(open squares, LDN; closed triangles, ODN). *p < value 0.05 after correction for the difference  
in baseline values.
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Discussion
Ever since the first successful laparoscopic donor nephrectomy, the safety of this procedure for 
donor and recipient has been questioned. It is commonly known that pneumoperitoneum, necessary for 
the laparoscopic technique may cause intraoperative adverse cardiovascular and renal effects 9. This 
study was conducted to investigate renal function (serum creatinine) in donor and recipient after ODN 
and LDN. We found a significantly higher serum creatinine in LDN donors on day 1, 3 months, and 1 year 
after donation. Also, serum creatinine postdonation remained 40% higher than preoperative values. 
In recipients, serum creatinine was significantly higher in the LDN group during the first week after 
transplantation. 
A clinical study by Ratner et al., comparing graft function in recipients after ODN and LDN, 
showed a higher serum creatinine on day 2 and 3 in the laparoscopic group 11. Also, Nogueira et al. 
found a significant higher serum creatinine during the first week after transplantation in recipients 
of laparoscopically procured kidneys 10. In accordance with their findings, we also found higher 
serum creatinine levels in recipients of laparoscopically procured kidneys in the first week after 
transplantation. After the first week, however, serum creatinine levels were comparable until three 
years posttransplant. There seems to be a short-term graft dysfunction in kidneys after laparoscopic 
donor nephrectomy compared to the kidneys from open donor nephrectomy. The laparoscopic and 
open groups in this study differ significantly with respect to the origin of the donor (living related or 
unrelated) and age. It is, however, not very likely that this difference is the main causal factor for the 
short-term graft dysfunction. Terasaki et al. reported similar graft survival rates of unrelated kidney 
grafts compared to related kidney grafts 1. With respect to the age, studies show a decreased graft 
survival in younger recipients compared to older recipients. The higher serum creatinine levels in the 
LDN group can not be explained by the age difference since the ODN group was younger 17,18. Finally, after 
Figure 2.3. 
Bar chart representing serum creatinine
Grey represents LDN, Black represents ODN
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adjusting for the differences between the two groups for age and origin, serum creatinine levels remained 
significantly higher the first week posttransplantation in the LDN group. 
One very important discriminating factor between ODN and LDN is the pneumoperitoneum. This 
may explain the higher serum creatinine levels we found in the first week posttransplantation. In an animal 
model, Kirsch et al. showed that with an intra abdominal pressure (IAP) of 10 mmHg the blood flow in 
the caval vein was decreased by 54% and the aortic blood flow by 7%. Also, urine output was decreased 
and creatinine levels were elevated 19. McDougall et al. demonstrated a significant decrease in renal vein 
flow concomitant with a drop in urine output at a pressure of 15 mmHg 20. These effects persisted for 
several hours after desufflation. This transient renal dysfunction has been well documented and various 
mechanisms have been described to explain these changes, which are probably multi factorial. Proposed 
mechanisms include decreased cardiac output, renal vein compression, ureteral obstruction, renal 
parenchymal compression and systemic and regional hormonal effects. Cisek et al., in an animal model, 
performed renal reductive surgery and applied 20 mmHg IAP for 6 hr 21. Dramatic drops in urine output 
(80%), GFR (63%), and renal blood flow (20%) were noted with concomitant acute renal failure related 
to tubular cell injury, without chronic renal failure. These observed blood flow changes suggested the 
possibility of renal tubular damage secondary to ischemia as a cause of oliguria during pneumoperitoneum. 
Altintas et al. showed significant histologic changes in rabbit kidneys after only 1 hr of pneumoperitoneum 
with pressures up to 15 mmHg 22. Several authors, however, report reduced urine output and GFR without 
chronic damage to the tubula. Lee et al. found no histologic damage after 5 hr of pneumoperitoneum 
in a rat study, McDougall et al. confirmed a lack of histologic abnormality in kidneys rendered oliguric at 
pressures of 15 mmHg 23,20. To counteract the effects of pneumoperitoneum expert anaesthesiologists 
and intense volume management are of major importance 24. Also, it should be noted that intra-abdominal 
pressures must be as low as possible; keeping in mind that retroperitoneal donor nephrectomy does not 
require pneumoperitoneum, avoiding any negative effects of increased intra-abdominal pressure. 
A decreased renal flow due to increased intra abdominal pressure might not only have a negative 
effect on the graft, but also on the remaining kidney in the donor. Serum creatinine levels in donors were 
significantly higher after LDN. Renal clearance is determined by renal blood flow and GFR, (µmol/L) of 
the donor in comparison to predonation values in time (light grey bars, LDN; dark grey bars, ODN). both 
are deprived during pneumoperitoneum up to 75% 25. This so called prerenal azotemia (insufficient renal 
blood flow) leads to hormone release, which enhances hormonal directed tubular reabsorption and induces 
systemic and renal afferent artery vasoconstriction. Normally, prerenal azotemia leads predominantly to 
tubular ischemia and could lead to acute renal failure 26. Interestingly, it has been demonstrated that the 
autoregulatory behavior of renal circulation is lost in laboratory animals with postischemic acute renal 
failure 27. Of interest is that in both groups serum creatinine levels remained 40% higher than preoperative 
levels for both groups, comparable to Goldfarb et al. who found an increase of approximately 30% 15. After 
unilateral nephrectomy, in literature creatinine clearance decreases by approximately 35% 2,15. 
We acknowledge the fact that this is a retrospective study with significant differences in cohorts. 
Although, after adjusting for these differences with regression analysis the higher levels serum creatinine 
in LDN recipient the first week remained. We are currently monitoring LDN and ODN renal function in donor 
and recipient in a prospective fashion.
In conclusion, this retrospective study shows higher serum creatinine levels in recipients of 
laparoscopically procured kidneys in the first week after transplantation. It is reassuring that these levels 
normalize to comparable levels in ODNrecipients, until 3 years posttransplantation. Serum creatinine 
was found to be higher in the first year after donation in LDNdonors compared toODNdonors. Although 
serum creatinine from 1 year until 3 years posttransplant are comparable for LDN and ODN groups, serum 
creatinine levels remain approximately 40% higher than preoperative values.
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Abstract
Background: Pneumoperitoneum (PP) as used for laparoscopic procedures, impairs stroke 
volume, renal blood flow, glomerular filtration rate and urine output. This study investigated whether 
peri-operative fluid management can abolish these negative effects of PP on hemodynamics.
Methods: Twenty-one patients undergoing laparoscopic donor nephrectomy (LDN) were 
randomized into three groups: group 1 received overnight infusion and received a bolus of colloid before 
induction of anesthesia, followed by a bolus just before PP; group 2 received overnight infusion and a 
colloid bolus before anesthesia; group 3 served as controls and received only infusion during operation. 
All three groups received the same total amount of crystalloids and colloids until nephrectomy. Data 
analysis of the donor included: mean arterial pressure (MAP), stroke volume (SV), left ventricular 
ejection time (LVETc), peri-operative urine output and renal function measured as the creatinine 
clearance (CrCl) until one-year post-transplantation. 
Results: SV was significantly higher in group 1 compared to controls for all measurements.  
In the control group SV significantly decreased after changing from supine to lateral position whereas 
there was no change in SV in both pre-hydrated groups. In all groups, MAP decreased after induction of 
anesthesia, and restored to pre-anesthetic values during PP. CrCl decreased in the control group during 
PP, but not in the other groups. From 2 days postoperative, CrCl was comparable between the three 
study groups. 
Conclusion: Overnight infusion and a bolus of colloid just before induction of PP attenuate 
hemodynamic compromise from PP. 
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Introduction
Laparoscopic donor nephrectomy (LDN) has become the method of choice to procure 
kidneys from living donors, mainly because of the reduced procedure-related morbidity and faster 
convalescence period 1-3. Despite the benefits to the donor, there are concerns over the transient 
deterioration of renal function in the recipient of the kidney procured by the laparoscopic technique, 
compared with open donor nephrectomy (ODN) 2,4-6. The exact mechanism of delayed graft function 
after LDN is not fully understood.
Pneumoperitoneum (PP) elevates intra-abdominal pressure (IAP), causing a decrease in renal 
blood flow (RBF) and glomerular filtration rate (GFR) resulting in oliguria 7-10. In an animal model, 
London et al. have shown that PP resulted in a decrease in RBF during normal saline infusion, whereas 
RBF did not decrease if volume expansion was given 11. From these results vigorous hydration up to 2 l/h 
of crystalloids during LDN in patients has nowadays been advocated 1,12-15. 
In 52 patients, Bergman et al. 16 found, however, no difference in graft function after LDN 
between aggressive (> 10 ml.kg-1.h-1) and conservative (< 10 ml.kg-1.h-1) intra-operative fluid management. 
Volume loading after establishment of PP is perhaps too late in order to counterbalance the collapsed 
venal system. Biancofiore et al. 17 studied the effect of volume loading on graft function with a 
crystalloid infusion starting the night before surgery. Early graft function did not differ between ODN 
and LDN, although the serum creatinine declined earlier, but not significantly, in those receiving kidneys 
from ODN procedure. 
Fasting before operation and induction of anesthesia leads to relative hypovolemia and the goal 
is therefore to compensate this before PP is started. In this study, we compared three different fluid 
regimes in LDN patients, in which the effect of pre-hydration together with a bolus of colloids given just 
before induction of anesthesia and a second one just before inflation of PP on hemodynamics was of 
special interest.
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Group n
ml RL.IBW-1.h-1
prehydration
ml RL.IBW-1.h-1
peroperative
ml HES.IBW-1 
before induction
ml HES.IBW-1 
before PP
ml HES.IBW.-1h-1
after PP
ml HES.IBW-1
total
1 7 3 13 6 6 12
2 7 2 13 6 3x2 12
3 7 16 3x4 12
Patients and methods
Patients undergoing LDN from June 2001 to November 2001 (N=21) were included in the study. 
The anesthetic procedure was performed according to a strict protocol for medication, ventilation and 
fluid regimen. In our hospital the donor patients are admitted the day before the operation, they are 
fasted during the night from 0.00 o’clock and operated on at 8.00 0’clock the next morning. Patients 
were randomized the day before operation by sealed envelopes by the responsible anesthetist to three 
different fluid regimens (Table 3.1): in Group 1 fluid administration was started at 10 pm the day before 
operation with 3 ml.ideal body weight (IBW)-1.h1 Ringers Lactate (RL) until operation. Before induction of 
anesthesia, the patients received 6 ml.IBW-1 of colloid (6% HES 130/0.4), thereafter 13 ml.BW-1.h-1 RL was 
started until nephrectomy, before installation of PP another bolus of 6 ml.IBW-1 colloid was given. Group 
2 received overnight infusion in the same way as in group 1 and a bolus of 6 ml.IBW-1 colloid just before 
induction. During operation, an infusion was started with 13 ml.IBW-1.h-1 RL and 2 ml/IBW/h of colloid 
was given for three hours. Group 3 was fasted from 0.00 o’clock on day of operation and received only 
an infusion during operation with 13 ml. IBW-1.h-1 RL and 4 ml.IBW-1.h-1 of colloid for three hours. After 
nephrectomy infusion protocol was adjusted, so that exactly six hours after start of operation all the 
patients had received in total 9 ml.IBW-1.h-1 RL. Patients were fitted with anti-thrombosis stockings. 
Induction of anesthesia was performed with propofol (2 mg.kg-1) after a bolus of sufentanil  
(0.3 µg.kg-1). Muscle relaxation was achieved with rocuronium (0.8 mg.kg-1) and monitored by train-of-
four (TOF) guard, a bolus of rocuronium (0.3 mg.kg-1) was given by 3 or more twitches. Anesthesia was 
maintained with propofol by continuous infusion (4-11 mg.kg-1.h-1), aiming at a bispectral index between 
45 and 55 (BIS monitor; Aspect Medical Systems, Newton, MA, USA), and analgesia was achieved 
by continuous infusion of sufentanil (0.4 µg.kg -1.h-1) until nephrectomy. One hour after the start of 
operation 20 g mannitol was given intravenously. 
After intubation all patients were ventilated in a pressure-controlled mode using a closed-
loop ventilator (Physioflex®, Dräger, Lübeck, Germany) with the following initial settings: FiO2 of 0.4, 
positive end-expiratory pressure (PEEP) of 7 cm H2O and peak inspiratory pressure (PIP) of 22 cm 
Table 3.1 
Infusion protocol used in the three groups
Column 2 n = number of patients
Column 3 Prehydration from 10.00 pm the day before laparoscopic donor nephrectomy, until operation.
Column 4 The amount of Ringer’s Lactate given during operation, until nephrectomy in ml.IBW-1.h-1.
Column 5 Amount of 6% HES 130/0.4 given before induction of anesthesia.
Column 6 Amount of 6% HES 130/0.4 given before installation of pneumoperitoneum.
Column 7 Amount of 6% HES 130/0.4 given per hour after installation of pneumoperitoneum.
IBW = ideal body weight 
HES = 6% HES 130/0.4
RL = ringers lactate
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H2O. Ventilation frequency was adjusted to keep PetCO2 between 4 and 5.5 kPa. After induction of 
anesthesia and before positioning of the patient, an esophageal Doppler probe (HemoSonicTM 100, 
Arrow International Inc., Reading, PA, USA) was positioned for measuring stroke volume (SV) and left 
ventricular ejection time, corrected for heart rate (LVETc) 18-20. 
After positioning the patient in full lateral nephrectomy position, PP was installed with an IAP 
of 12 mmHg, which was constantly maintained at this level. The same team of anesthesiologists and 
surgeons did all operations. The surgical techniques have been described in detail elsewhere 21.
Mean arterial pressure (MAP) and SV (available after induction of anesthesia) were monitored 
non-invasively every 5 minutes. Urine output was measured from 22.00 the day before until the 
introduction of PP (T0), then urine output was measured every hour up to 6 hours hereafter (T1-6). 
Blood samples of the donors were collected to determine creatinine levels the day before operation, 
after induction of anesthesia, 6 hours after installation of PP, two days, one month, and 1 year after 
operation. Creatinine clearance (CrCl) was determined using the Cockcroft-Gault formula 22.
Statistics
Data analysis was performed using SPSS for Windows (version 14.0, SPSS Inc., Chicago, USA). 
Data are presented as means with standard deviation (SD). Differences between the groups were 
analyzed using the independent t-test, depending on the Levene’s test, pooled or not pooled.  Repeated 
measures with a general linear model from SPSS were used to assess significance for CrCl. A p-value 
<0.05 (two-sided) was considered statistically significant.
Results
Baseline characteristics are shown in Table 3.2 and were comparable between the three groups. 
After induction of anesthesia, SV was significantly higher in both pre-hydrated groups compared to 
the control group (Fig. 3.1). After repositioning from supine to lateral, SV decreased significantly in the 
control group whereas not in groups 1 and 2 (Fig. 3.1). After instillation of PP, SV remained stable in 
group 1 but not in groups 2 and 3 (Fig. 3.1). 
After induction, LVETc was higher in group 1 compared to the control group during the whole 
procedure and remained stable (Table 3.3). In all groups MAP decreased after induction of anesthesia; 
in the control group MAP decreased significantly more compared to group 1 (p = 0.03). HR was 
comparable between the 3 groups (Table 3.3). 
group 1 group 2 group 3
Age (yrs) 56 (11) 53 (9) 55 (12)
Weight (kg) 72 (9) 82 (8) 74 (7)
IBW (kg) 70 (8) 78 (8) 71 (6)
Male/female 2/5 4/3 3/4
Operation time (min) 237 (37) 251 (46) 226 (31)
IBW = ideal body weight 
Data are mean (SD)
Table 3.2 
Demographic data on the three groups
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preop supine lateral PP30 PP60 PP90 PP120
HR
group 1 65 (6) 65 (13) 63 (20) 60 (9) 61 (8) 60 (10) 61 (9)
group 2 63 (11) 60 (9) 61 (14) 62 (11) 61 (9) 63 (6) 63 (8)
group 3/control 73 (9) 69 (14) 61 (6) 65 (10) 63 (6) 60 (7) 61 (6)
MAP
group 1 102 (11) 85 (13)* # 81 (19)* 93 (14) 96 (15) 94 (17) 98 (20)
group 2 102 (14) 73 (10)* 81 (15)* 107 (10) 107 (18) 104 (8) 102 (12)
group 3/control 105 (12) 70 (11)* 79 (7)* 103 (9) 98 (11) 95 (12) 95 (15)
LVETc
group 1 336 (19)# 339 (20)# 355 (26)# 345 (31) 335 (30) 336 (33)
group 2 313 (29) 308 (39) 295 (58)° 311 (20)° 308 (27) 300 (28)
group 3/control 294 (26) 284 (31) 292 (26) 307 (18) 309 (18) 311 (25)
Table 3.3 
Data on hemodynamic parameters
* p < 0.05 versus preoperative values
# p < 0.05 group 1 and 2 versus control group
° p < 0.05 group 1 versus group  2
Data are mean (SD)
Column 1; HR=heart rate, MAP=mean arterial pressure, LVETc=left ventricular ejection time
Column 2; preop; before anesthesia
Column 3;  supine;  after induction of anesthesia, supine position
Column 4;  lateral;  full lateral position
Column 5;  PP30;  mean measurement the first 30 minutes after installation of pneumoperitoneum
Column 6;  PP60;  mean measurement the second 30 minutes after installation of pneumoperitoneum 
Column 7;  PP90;  mean measurement the third 30 minutes after installation of pneumoperitoneum 
Column 8;  PP120; mean measurement the fourth 30 minutes after installation of pneumoperitoneum 
Urine output, measured from the start of operation until the moment of kidney extraction,  
was 1.9  ml.kg-1.h-1 (range 1.2-3.2) for group 1, 1.4 ml.kg-1.h-1 (range 0.8-2.3) for group 2, and 1.1 ml.kg-1.h-1 
(range 0.6-1.6) for group 3. In controls, the urine production was significantly lower compared to group 
1 (p=0.01). CrCl decreased in the control group directly after PP, but not in the other groups (Table 3.4). 
From 2 days postoperative, CrCl was comparable between the 3 study groups (Table 3.4). 
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Figure 3.1 
Stroke volume changes during laparoscopic donor nephrectomy, 
comparing three different fluid regimens
# p < 0.05 group 1 and 2 versus control group
° p < 0.05 group 1 versus group  2
x p < 0.05 versus supine position
Data are mean (two times standard deviation)
Discussion
This study showed that during LDN preoperative hydration together with a bolus of colloid given 
before induction of anesthesia and before installation of PP resulted in higher SV and more urine 
output compared to a fluid regimen with only an intra-operative aggressive fluid infusion. Also the 
second group, that received no bolus of colloid before PP compared to group 1, showed a significant 
reduction in SV after installation of PP. In the control group, LVETc and urine output at the moment 
of kidney extraction showed significantly lower values compared to both pre-hydration groups. CrCl 
values six hours after start of the operation was significantly reduced in the control group compared 
to pre-operative values but not in the both pre-hydrated groups; this difference was reduced two days 
postoperatively. 
Clinical studies yield conflicting data concerning the effect of LDN on recipient graft function 
compared to ODN. The largest study to date compared more than 5000 kidney transplants from 
a database and found that LDN was associated with slower early graft function compared to 
ODN. However, renal function and graft survival at 1 year was similar between both groups. This 
was confirmed by retrospective analysis of 120 LDN and 100 ODN in our own institution in which 
serum creatinine in the recipients was significantly higher in the LDN group only in the first week 
after transplantation 4. One very important discriminating factor between ODN and LDN is the 
pneumoperitoneum. From experimental studies it has become clear that PP decreases RBF and that 
the magnitude of this decrease is affected by the IAP used, the volume status, and positioning. To 
counterbalance the increased IAP, vigorous intravenous hydration during LDN has nowadays been 
recommended in an attempt to optimize preload and promote diuresis but randomized clinical data are 
missing. In a porcine model, Demyttenaere et al. 23  showed that the decrease in SV and renal cortical 
perfusion could be prevented by a simple hydration of 15 ml.kg.-1h-1 saline combined with a bolus 20 
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group 1 group 2 Control group 3
CrCl preop (ml.min-1) 89 (19) 101 (25) 102 (34)
CrCl after induction (ml.min-1) 104 (18) 109 (20) 96 (31)
CrCl after the operation (ml.min-1) 87 (17) 94 (14) 73 (23)ª
CrCl D2 (ml.min-1) 63 (10)* 65 (11)* 64 (19)*
CrCl 1 month (ml.min-1) 63 (12)* 67 (11)* 63 (24)*
CrCl 1 year (ml.min-1) 71 (13) 71 (13)* 66 (25)*
Table 3.4 
Data on creatinine clearance in the three groups
* p < 0.05 versus preoperative values
ª p < 0.05 difference between CrCl preop and CrCl after operation, control group versus group 1 and 2 
Data are mean (SD)
CrCl preop;   creatinine clearance one day before operation
CrCl after induction;  creatinine clearance just after induction of anesthesia
CrCl after the operation;  creatinine clearance at around 14.30 pm, 6 hours after installation of pneumoperitoneum T6 
CrClD2;  creatinine clearance two days after operation
CrCl1month;  creatinine clearance one month after operation
CrCl1year;   creatinine clearance one year after operation 
 
ml.kg-1 saline, in accordance with the findings of London et al. 11 This was also seen in the present study 
in which pre-hydration with a normal infusion with crystalloids during operation combined with a bolus 
of colloids just before PP did not decrease SV and improved diuresis. Besides PP, the kidney lateral 
decubitus position, which is an anti-Trendelenburg position, contributes to hemodynamic alterations 
by decreasing preload through the effect of gravity on venous return 24. Yokoyama et al. 25 found no 
significant change in hemodynamic values after postural change of their patients from supine to lateral 
but a significant reduction in SV after postural change to kidney position; these patients received a 
fluid regime of 20 ml.kg-1.h-1 of crystalloids. This was confirmed by our study in which the control group 
showed a significant reduction in SV after postural change from supine to kidney position whereas 
there was no reduction in both pre-hydrated groups which received a bolus of colloid just before 
induction (Fig. 3.1). 
After prehydration with crystalloids we infused colloids to achieve optimal plasma expansion 
just before installation of PP 26. In our hospital we use 6% HES 130/0.4 for fluid expansion, because 
the rate for anaphylactic reactions is considerably lower than for gelatin products 27. However, there 
are concerns that infusion of certain HES types may influence kidney function 28. As long adequate 
hydration using sufficient amounts of crystalloids are used, the latest generation of HES products (6% 
HES 130/0.4) does not increase the risk for renal dysfunction even when used in large amounts 29-30. 
Lang et al. 31 even demonstrated that 6% HES 130/0.4 improved tissue oxygenation during and after 
major surgical procedures, compared with a crystalloid-based volume strategy. 
In this study, we used the HemoSonicTM, a Transoesophageal Doppler ultrasonography (TOD) 
device, to measure blood flow in the descending aorta. Several studies have confirmed a good 
correlation with cardiac output measured by the thermodilution technique 18-32. It is shown that the 
accuracy of the device is somewhat operator-dependent 20  and therefore the same 2 persons did all 
the measurements with this device in the present study. Feldman et al., used LVET to guide their fluid 
management in LDN patients 33. In the present study it was shown that LVETc was significantly lower 
in the control group that did not received pre-hydration and increased over time (Table 3.2). It should, 
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however, be taken into account that the blood flow with this device is measured in the descending aorta, 
which is around 70% of the total cardiac output. This could be of influence on our measurements if 
redistribution of flow away from the descending aorta occurs because of elevated IAP and this is more 
pronounced in hypovolemic patients. 
Some other limitations of this study should be noted. In only 4 patients a MAG3 scan was 
performed which provides the distribution of the function from the two kidneys of the donor. In the 
four measured patients the harvested kidney contributed 43- 48% of the total kidney function, these 
four patients were divided over all three study groups. However because we do not have the data on 
the other patients, this could have biased our data on postoperative CrCl. Prehydration of the donor 
patients conform our protocol, started the night before operation, which contradicts fast track surgery 
were kidney donor patients are admitted to hospital on the day of surgery. Also these patients can 
receive adequate prehydration, but further research should be done. 
In this study we focused on intraoperative hemodynamic changes, our data show that 
preoperative hydration together with a colloid bolus given before induction of anesthesia and before 
installation of PP resulted in higher SV and more urine output during LDN, compared to controls that 
received only an aggressive intra-operative infusion. While under-hydration may contribute to renal 
dysfunction, perioperative fluid excess can also cause problems, such as pulmonary edema, ileus and 
increased risk of cardiopulmonary and wound healing complications, which might results in longer 
hospital stay 34. However, there is a need to ensure adequate hydration status during PP without being 
over-aggressive. First, our fluid regime will be tested in a large prospective study in order to prevent the 
negative effect of PP on early graft function in the recipient, and to study the possible side effects in 
the donor. 
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Abstract
Background: Carbon dioxide (CO2) pneumoperitoneum (PP) increases mean arterial blood 
pressure (MAP) and systemic vascular resistance (SVR) but decreases stroke volume (SV) and cardiac 
output (CO). This study evaluated the hemodynamic effects of elevated intra-abdominal pressure (IAP), 
occurring during laparoscopic donor nephrectomy (LDN).
Methods: Twenty-two patients undergoing LDN were investigated and hemodynamic parameters, 
PvCO2 (carbon dioxide partial pressure), and VCO2 (carbon dioxide production) were monitored during 
the procedure. Before and after PP, IAP was raised from 12 to 20 mmHg and the hemodynamic effects 
were measured every 30 seconds. 
Results: During IAP of 12mmHg and stable serum CO2, there was no change in SV, compared to 
preinsufflation levels. When IAP was elevated from 12 to 20 mmHg, SV initially decreased (p < 0.05), 
followed by an increase in MAP and SVR (p < 0.05).
Conclusion: This study shows that with the fluid and ventilation protocol used, PP has no 
significant effect on SV at an IAP of 12 mmHg, whereas increasing IAP to 20 mmHg does. In this 
study the hemodynamic effects induced by CO2 PP of 12 mmHg are not due to changes in serum CO2. 
Compression of the venous system during PP of 20 mmHg reduces preload with a subsequent increase 
in SVR.
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Introduction
There has been a dramatic increase in laparoscopic procedures, mainly because of the 
consequent reduction in procedure-related morbidity. Advances in laparoscopic techniques have made 
procedures such as laparoscopic donor nephrectomy (LDN) possible. It has been shown, that increased 
intra-abdominal pressure (IAP) during carbon dioxide pneumoperitoneum (CO2 PP) is associated with 
increased mean arterial blood pressure (MAP) and systemic vascular resistance (SVR), together with 
decreased stroke volume (SV) 1,2. In addition, impaired renal blood flow (RBF) and glomerular filtration 
rate (GFR), with oliguria and anuria have been reported 3-6. Various mechanisms, such as venous 
compression caused by elevated IAP (with compression of abdominal vasculature and organs), and the 
pharmacological action of the absorbed CO2, have been proposed to explain these transient adverse 
hemodynamic and renal effects 7-11. 
To analyze the mechanisms occurring perioperatively during PP, we studied the hemodynamic 
changes on line with new Doppler techniques. This technology enables SV, left ventricular contraction 
and preload to be measured on a beat-to-beat basis 12. 
The aim of the study was to determine the effect of IAP elevation on hemodynamic parameters 
during CO2 PP for LDN.
Patients and methods
The local ethical committee of the Erasmus Medical Center approved this study. From November 
2001 to November 2002, twenty-two patients undergoing LDN were included in the study. Exclusion 
criteria were the use of ß-blockers and Ca antagonists. All patients were classified as ASA 1 or 2. 
Patients received 1000 mg paracetamol 1 h before operation and were fitted with anti-embolic 
stockings.
The anesthetic procedure was performed according to a strict protocol for medication, ventilation 
and fluid regimen. Ideal body weight (IBW) was calculated according to body height, gender and age. 
Peri-operative fluid management was as follows: the day before operation intravenous fluid 
administration was started at 10 PM, with 3 ml. IBW-1.h-1 Ringer’s lactate (RL) until the operation. Before 
induction of anesthesia, the patients received 6 ml.IBW-1 of 6% hetastarch 130/0.4, thereafter ml. 
IBW-1.h-1  RL was started, and before initiating PP another bolus of 6 ml.IBW-1 6% hetastarch 130/0.4 
was given. Induction of anesthesia was performed with 2 mg.IBW-1 propofol 1% after 0.3 µg.IBW-1 of 
sufentanil. Muscle relaxation was achieved with 0.8 mg.IBW-1 of rocuronium. Anesthesia was continued 
with propofol 1% with 40% oxygen aiming at a bispectral index between 45 and 55 (BIS monitor; Aspect 
Medical Systems, Newton, MA,USA), and analgesia was given by continuous infusion of 0.4-µg.IBW –1.h-1 
sufentanil. Muscle relaxation was monitored by train of four (TOF) ulna nerve stimulation guard, and 
kept under 3 twitches at 60 mA stimulation. Rocuronium 10 to 20 mg was given when necessary. One 
hour after the start of operation 20 g mannitol (100 cc, 20%) was given. Lungs were ventilated with 
a closed-loop ventilator (Physioflex®, Dräger, Lübeck, Germany). Initially, the same ventilator settings 
were used in all patients: pressure controlled ventilation (PCV), positive end-expiratory pressure (PEEP) 
7 cm H2O and peak inspiratory pressure (PIP) of 22 cm H2O, with first ventilation frequency and (where 
necessary) PIP were adjusted as required to keep PetCO2 between 4 and 5.5 kPa.
After induction of anesthesia, a NICO monitor (Novametrix, Medical Systems Inc., Wallingford, CT, 
USA), and an esophageal Doppler probe (HemoSonicTM 100, Arrow International Inc., Reading, PA, USA) 
were installed. The NICO monitor was used to measure CO2 output per minute (VCO2). The HemoSonic 
device was used to measure SV, and left ventricular ejection time (LVET), which is a parameter for 
preload and acceleration (Acc), which is a parameter for contractility of the left ventricle measured in 
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N = 22
Age in years, mean (range) 47 (21-70)
Sex  Males 12
        Females 10
Weight in kg, mean (range) 82 (50-118)
IBW in kg, mean (range) 76 (55-100)
Operated side  Left 14
                          Right 8
Table 4.1 
Demographic data on the 22 study patients, undergoing laparoscopic donor nephrectomy.
 IBW; ideal body weight
the aorta descendens 13; cardiac output (CO) and SVR were calculated using the HemoSonic device. 
MAP was monitored non-invasively every 5 min; HemoSonic parameters (available after induction 
of anesthesia and intubation) were monitored every 15 s. After induction of anesthesia a venous 
blood sample was collected to determine pH and PvCO2. After the patient was positioned in the lateral 
decubitus position, PP was installed with an IAP of 12 mmHg. Data were recorded in the supine position 
before and after induction of anesthesia: directly after lateral positioning; and in the 1st, 2nd and 3rd hour 
of PP.
Two additional periods of separate measurement were made at the beginning of PP (period A) 
and at the end of PP (period B), in which the IAP was raised from 12 to 20 mmHg.
During period A, data collection was started after stabilization of hemodynamic parameters for 
10 min, with an IAP of 12 mmHg. Venous blood samples were collected to determine pH and PvCO2, 
and two sets of data (VCO2, CO, SV, LVET, Acc, MAP, SVR) were recorded at an IAP of 12 mmHg (level 
1). Hereafter, an IAP of 20 mmHg was installed in 30 sec (level 2); for 3 min hereafter, six sets of data 
were recorded. Then IAP was lowered again to 12 mmHg in 30 sec (level 1) and four sets of data were 
recorded, in the following 2 min. During this procedure the ventilator setting and the anesthesia 
protocol remained unchanged. The surgical procedure was then started. During period B, after 
nephrectomy, the same data were collected in the same way as in period A.
Statistics
Data were analyzed using SPSS for Windows (version 10). Data are presented as means and SD. 
Differences measured during PP over time were analyzed with repeated-measures analysis of variance 
(ANOVA). Differences between period A and B were analyzed using paired sample t-tests. 
Statistical significance was accepted at p < 0.05.
Results
Table 4.1 gives the demographic data for the 22 patients included in the study. Mean propofol 
infusion during the study period was 7 mg.kg. -1h-1.  After induction of anesthesia and positioning of the 
patient in the lateral position mean MAP decreased from 99 mmHg to 78 mmHg (p < 0.001), but then 
increased significantly during the 1st to 3rd hour of PP (91 mmHg; range, 65-125) (Table 2). After lateral 
positioning, SV decreased (15%; p = 0.044), but induction of an IAP of 12 mmHg had no significant effect on 
SV (Table 4.2). There was no significant change in heart rate (mean, 68 b/min) during the entire procedure. 
Between period A and B the mean duration of PP was 190 (range, 112-249) min. During this period 
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MAP (mmHg) p-value SV (ml) p-value
Time 1
Before anesthesia 99 (17.1)
Time 2
Supine position after induction of anesthesia 82 (17.6) 0.0017 93 (20)
Time 3
Lateral nephrectomy position 78 (17.8) n.s. 79 (21) 0.044
Time 4
First hour of pneumoperitoneum 91 (17.8) 0.006 84 (23) n.s.
Time 5
Second hour of pneumoperitoneum 90 (17.7) n.s. 82 (19) n.s.
Time 6
Third hour of pneumoperitoneum 94 (19.5) n.s.
Table 4.2
Data on mean arterial pressure (MAP) and cardiac output (CO) during  
laparoscopic donor nephrectomy.
Data are mean (standard deviation); n.s. = nonsignificant
MAP and SV were compared with the previous outcome
Period A Period B p-value
VCO2 182 (46.2) 218 (42.3) 0.014
pH 7.37 (0.04) 7.35 (0.04) n.s.
PvCO2 5.82 (0.69) 5.84 (0.69) n.s.
Table 4.3 
Data on VCO2, pH and PvCO2  at the beginning of period A and B.
Data are mean (standard deviation); n.s. = nonsignificant
Values for Period A and B were compared with each other. 
VCO2 rose significantly from 182 (range, 82-250) to 218 ml.min-1 (range, 134-310); (p = 0.014). Minute 
ventilation was raised with 8%, mainly by an increase in frequency from 11 to 14 times per min (27%); 
PIP was reased from 23 to 25 kPa (9%).
A comparison of LVETc before period A and before period B showed no significant change. 
Venous pH and PvCO2 did not change during ventilation and between period A and B, and it stayed 
within physiologic limits (Table 4.3).  After IAP was increased from 12 to 20 mmHg in period A and B, 
there was a significant and immediate (within 90 sec) reduction in SV and CO. There was a significant 
increase in MAP and SVR, within 120 s (figure 4.1a and 4.1b). Ventricular contraction measured with 
acceleration did not change (mean13 ± 4) during the increase in IAP from 12 to 20 mmHg. 
Mean changes in SV and MAP during period A and B are given in Table 4.4. Mean blood loss  
was 283 ml. 
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Figure 4.1a Stroke volume  , cardiac output  , and heart rate   every 30 seconds at 12 and 20 mmHg intra-
abdominal pressure (IAP), in period A and B. 
Figure 4.1b Stroke volume  and Mean arterial blood pressure  every 30 seconds at 12 and 20 mmHg intra-abdominal 
pressure (IAP), in period A and B. 
Between two IAP levels 30 seconds were needed to achieve the desired IAP. 
* Significant difference for SV, time 180s vs. 30 and 60s
^ Significant difference for CO, time 180s vs. 30 and 60s
+ Significant difference for MAP, time 180s vs. 30 and 60s
(T test, p- value< 0.05)
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Figure 4.1a
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IAP 12 mmHg IAP 20 mmHg p-value IAP 20 mmHg p-value
SV ml (SD) 84 (24) 78 (21) 0.016* 80 (21) 0.018*
MAP mmHg (SD) 91 (16) 101 (15) 0.001* 98 (14) 0.011*
SVR (SD) 1581 (634) 1874 (795) 0.001* 1753 (797) 0.006*
Table 4.4 
Data on stroke volume (SV), mean arterial pressure (MAP) and systemic vascular resistance 
(SVR) in laparoscopic donor nephrectomy, during a period of elevated IAP (from 12 to 20 mmHg), 
Period A
IAP 12 mmHg IAP 20 mmHg p-value IAP 20 mmHg p-value
SV ml (SD) 83 (19) 76 (20) 0.001* 80 (20) 0.001*
MAP mmHg (SD) 98 (21) 103 (21) 0.001* 98 (19) 0.001*
SVR (SD) 1529 (540) 1763 (631) 0.001* 1530 (453) 0.001*
Period B
* Significant IAP 12 vs. IAP 20 and IAP 20 vs. IAP 12
Mean data of SV, MAP and TSVR during IAP 12 mmHg were compared with mean data of SV, MAP and TSVR during 
IAP elevation of 3 min to 20 mmHg. After pressure decrease back to 12 mmHg, data were compared again. Data were 
gathered every 30 sec.
Discussion
Laparoscopy requires the establishment of pneumoperitoneum to obtain adequate surgical 
exposure, and CO2 is still the most commonly used gas. The clinical importance of renal and 
cardiovascular changes has been tempered by the fact that most laparoscopic procedures are short and 
generally performed in relatively healthy subjects. However, with the rapid expansion of indications for 
laparoscopic surgery, more advanced and longer procedures, such as LDN, are now performed. 
In our study group, PP was induced with a mean duration of 190 min. During such a time period, 
in case of insufficient renal blood flow (pre-renal azotemia), ischemic renal injury can result in acute 
tubular necrosis in both the kidney for donation and the remaining kidney 1. The impaired postoperative 
short-term function of human LDN kidney transplants may be caused by the same mechanism 15,16; 
thus, prevention of PP-induced pre-renal azotemia is important. However, direct assessment of renal 
hemodynamic and renal tubular function is not easily obtained in the clinical setting. Instead as in this 
study, indirect variables such as MAP, SV, CVP and urine output (UO) are useful parameters. 
Both systemic CO2 accumulation and compression of vessels and organs due to increased IAP 
have been proposed as mechanisms that cause the negative effects on hemodynamics during CO2 PP 
3, 7-10. If the main cause is CO2 accumulation, then, because of the elevated PCO2, primarily systemic 
vascular resistance will increase and contractility of the left ventricle will be impaired. If the main cause 
is the increased IAP, then a decrease in preload will be expected because of vascular compression, 
followed by compensatory systemic vascular resistance increase.
This study was performed with the idea that the mechanical compression of organs and vessels 
is the main cause of the change in hemodynamics. Other studies have shown that the amount of 
hemodynamic reaction due to PP is greatly affected by intravascular volume, and changes in SV are 
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variable and often reflect changes in intravascular volume loading. In those studies augmentation of 
circulating intravascular blood volume attenuates these hemodynamic changes as well as the renal 
response during increased IAP. Therefore vigorous intra-operative hydration is now advised 16,18. 
In our study, an optimal intravascular volume was achieved, as confirmed by an optimal LVET. 
Due to our fluid management, SV did not change significantly after installation of an IAP of 12 mmHg; 
however it did change when the patient was positioned in the kidney rest lateral decubitus position 
(with legs are in the Trendelenburg position). Yokoyama et al.19 found comparable results when 
changing to the kidney rest lateral decubitus position; in this position, there was a reduction in MAP and 
SV, and SVR increased. Our study shows that intravascular volume shift after the position change is of 
primary importance for SV during the LDN procedure, whereas an increase in IAP to12 mmHg on its own 
did not suppress SV any further. 
During period A and B, when IAP was elevated from 12 to 20 mmHg for 3 min, an immediate 
and significant reduction of SV was observed within 90 s (Fig. 4.1a and b) followed by MAP and SVR 
elevation, which was significant after 120 s (Fig. 4.1b). Thus, with an increase in IAP from 12 to 20 mmHg, 
preload reduction is evident and this precedes afterload elevation; contractility of the heart measured 
during this procedure did not change. Changing IAP from 20 back to12 mmHg reversed the observed 
hemodynamic changes. 
At the start of periods A and B, we had expected a difference in PvCO2, because of the 
intraabdominal inflated CO2. There was a significant increase in VCO2 from the start of period A to B, 
but adjustment of the pressure-controlled ventilation enabled the maintenance of Pet CO2 and PvCO2 
at preinsufflation levels. First, we raised minute ventilation as necessary to maintain a stable Pet CO2, 
using frequency alone; this was done to ensure a minimum elevation in intrathoracal pressures.  
We needed to elevate PIP with only 9%. Our study in ASA I and II patients demonstrates that with 
sufficient alveolar ventilation and SV, it is possible to remove CO2 adequately. No hypercarbia or 
respiratory acidosis were observed during the 190 min of PP, despite a significant increase in VCO2. 
Thus, the elevation of SVR and MAP during an IAP of 12 mmHg, cannot be explained by hypercarbia. 
During the elevation in IAP from 12 to 20 mmHg (period A and B) ventilation was not adapted, and 
it is likely that PCO2 increased. However the hemodynamic changes occurred after only 30 seconds. 
We think it unlikely that changes in PCO2 or hormones are responsible for this quick change in 
hemodynamics. And ventricular contraction was not impaired during this procedure, probably indicating 
no substantial increase in PCO2.
Catecholamines, the renin-angiotensin-aldosteron system, and vasopressin are all released during 
PP, contributing to increased afterload 1,20-23. It is possible that hormone induction caused by increased 
IAP explains the increase in SVR and MAP that we observed during IAP of 12 mmHg. However because 
we did not measure hormones we are unable to draw conclusions about their influence.
In conclusion, appropriate ventilation and adequate volume status during LDN with an IAP 
of 12 mmHg is sufficient to prevent SV reduction. With a higher IAP level MAP, SV and SVR change 
considerably, and a primary reduction in preload is observed followed by an increase in afterload.  
This study demonstrates that hemodynamic stress due to PP during LDN is due to the reduction in 
preload that occurs as a result of caval and/or renal vein compression and elevated venous resistance.
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Abstract
Background. Laparoscopic donor nephrectomy (LDN) has been associated with delayed graft 
function compared with open donor nephrectomy (ODN). We have recently shown that the adverse 
effect of pneumoperitoneum (PP) on hemodynamics could be prevented by a new fluid regime. The aim 
of this study was to test the effect of this fluid regime on the kidney function of the donor and recipient 
after LDN and ODN.
Methods. We prospectively collected data of 51 donors undergoing ODN and 59 donors 
undergoing LDN as well as data from the corresponding recipients. Baseline characteristics of the two 
groups were comparable. All donors and recipients were treated with a standardized anesthesia and 
fluid regime. This fluid regime consisted of preoperative overnight hydration together with a bolus of 
colloid given before induction of anesthesia and before introduction of PP.  Follow-up was two years. 
Results. Hemodynamics and urine output until nephrectomy were comparable between both 
groups. Donor kidney function did not differ after ODN and LDN. Estimated glomerular filtration rate, 
graft survival and recipient survival did not differ between open and laparoscopic procured transplants. 
No adverse effects of the novel fluid regime (eg, pulmonary edema, or additional oxygen supply) were 
observed in the donors. 
Conclusion. In contrast to our earlier findings, the kidney function of the donor and recipient is 
comparable between ODN and LDN after introduction of a new fluid regime. 
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Introduction 
Kidney transplantation from live donors has become the preferred treatment for end-stage renal 
disease in many Western countries because of short waiting lists, excellent initial transplant function, 
and long average graft survival compared with transplantation from deceased donors 1. 
Laparoscopic donor nephrectomy (LDN) has become the gold standard to procure the transplant 
in live donors because this approach is associated with a less intense recovery phase and a superior 
quality of life compared with open surgery 2-5. However, serum creatinine values of the donor and 
recipient appeared to be temporarily higher after LDN and delayed graft function occurred more often 
6-11. Until the prognostic value of these findings on long-term renal function in donor and recipient is 
established, it is necessary to optimize short-term renal function of donor and recipient after LDN. 
The pneumoperitoneum (PP), which has to be established during LDN, is considered one of the 
causative factors affecting renal function 6,12,13. Clinical and experimental studies have demonstrated 
that increased intra-abdominal pressure (IAP) may disturb hemodynamics. This can result in oliguria 
and transient renal dysfunction because of impaired renal blood flow (RBF), which is, in turn caused by 
compression of the renal parenchyma and venous system 14-18. In an effort to minimize renal blunting, 
vigorous intra-operative hydration has been shown to prevent RBF decrease caused by PP 12,19-21. 
However, this did not correct the impaired creatinine clearance as observed during PP 12,19-21. In contrast, 
we have shown that preoperative hydration together with a bolus of colloid given before induction of 
anesthesia and before installation of PP resulted in higher stroke volume and more urine output during 
LDN, compared with controls, who received only an aggressive intra-operative infusion 22. 
While under hydration may contribute to renal dysfunction, perioperative fluid excess can also 
cause problems, such as pulmonary edema, ileus and increased risk of cardiopulmonary, and wound-
healing complications. 
In a prospective study investigating donor-experienced benefits after LDN versus ODN initiated 
by our surgeons, we studied whether this fluid regime, that combines aggressive preoperative and 
standardized intra-operative hydration, could solve the delayed graft function seen after LDN, but 
without side-effects for the donor after laparoscopic live kidney donation. 
Patients and methods
 
A total of 116 donors were scheduled for LDN between November 2001 and January 2004.  
Six donors were excluded from the present analysis because a different fluid regime was applied 
(n=4) or because the open surgical approach was different (n=2). Data of all the donors and the 
corresponding recipients were prospectively collected. These patients also participated in another  
study that investigated donor-experienced benefits after LDN versus ODN 2,23. The local medical  
ethics committee approved the study protocol. 
Overnight infusion with lactate Ringer’s solution (RL, 3 ml.kg -1.h-1) was started 10 hours before 
the operation. Before induction of anesthesia, the donor received a bolus of colloids (6 ml.kg-1; 6% 
Hetastarch 130/0.4-HES). During the operation, RL (13 ml.kg -1.h-1) was administered. Before inflation 
of the peritoneal cavity, a second bolus of colloids (6 ml.kg-1; 6% Hetastarch 130/0.4-HES) was 
administered. Each ml blood loss was replaced with HES (ratio 1:1). One hour after the start of surgery, 
20 g mannitol was administered intravenously. After nephrectomy the infusion protocol was adjusted, 
so that exactly six hours after start of operation all the patients had received in total 9 ml.kg -1.h-1 RL. 
Intra-operatively, anti-thrombotic stockings were routinely used to improve venous return. 
Induction of general anesthesia was performed with propofol (2 mg.kg-1); sufentanil (0.3 µg.kg-1) 
was also administered, and muscle relaxation was achieved with rocuronium (0.8 mg.kg-1).  
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Anesthesia was maintained with continuous infusion of propofol (3-12 mg.kg -1.h-1) or isoflurane (0.5-1.2%) 
maintaining the bispectral index between 40 and 60 (BIS monitor; Aspect Medical Systems, Newton, 
MA, USA). Analgesia was maintained by continuous infusion of sufentanil (0.4-µg.kg-1.h-1) until 
nephrectomy. At the end of the operation donors received an intravenous bolus of morphine  
(0.06 mg.kg-1). 
For postoperative pain management, all donors received an intravenous patient-controlled 
analgesia (PCA) pump with morphine (1 mg.ml-1, bolus 1 ml; lock-out time 5 minutes) and 1000 mg 
acetaminophen four times daily. The PCA device was removed when morphine had not been required 
for six hours.
After intubation, all patients were ventilated in a pressure-controlled mode using a closed-loop 
ventilator (Physioflex, Dräger, Lübeck, Germany) with the following initial settings: FiO2 of 0.4, positive 
end-expiratory pressure of 7 cm H2O, peak inspiratory pressure of 22 cm H2O. Ventilation frequency was 
adjusted to keep PetCO2 between 4 and 6 kPa.
After positioning the donor in a lateral decubitus position, an esophageal Doppler probe 
(HemoSonicTM 100, Arrow International Inc., Reading, PA, USA) was installed to measure stroke volume. 
The NICO (Novametrix, Medical Systems Inc., Wallingford, CT, USA) was placed between the patient and 
the ventilator, and was used to measure VCO2. 
After extubation, administration of oxygen was stopped if the oxygen saturation remained within 
2% of the preoperative values. Adverse effects of the fluid regime (such as pulmonary edema) were 
postoperatively checked by bilateral auscultation, and by non-invasive oxygen saturation monitoring 
during the first two hours after extubation.
The surgical techniques have been described in detail elsewhere 23. Both techniques were 
performed with the donor in a lateral decubitus position. Briefly, mini-incision ODN was performed  
with an 8 to 15 cm skin incision (depending on the body mass index) anterior to the eleventh intercostal 
space. The muscles of the abdominal wall were carefully split to access the retroperitoneal space. 
The abdomen was insufflated with CO2 to a pressure of 12 mmHg. The kidney was extracted through a 
Pfannenstiel incision with an endobag (Endocatch, US Surgical, Norwalk, USA). 
Urine output was measured from 10 hours before the operation (start of fluid infusion) until 
the introduction of PP (T0), urine output was then measured hourly until 6 hours thereafter (T1-6). 
Extubation time was documented from the last suture to the moment of extubation. Oxygen saturation 
was documented preoperatively and during the recovery period, which was planned to be two hours. 
Blood samples of the donors were collected preoperatively and at 1, 2, and 21 days, 2 and 
3 months and 1 and 2 years postoperatively. Blood samples of the recipients were collected 
preoperatively, daily until discharge (usually 10-14 days following transplantation), 1, 3, 6, and 9 months, 
and 1 and 2 years postoperatively. Creatinine clearance was estimated using the Cockcroft-Gault 
formula 24. Urine output during donor nephrectomy was quantified. Mean arterial pressure (MAP) and 
stroke volume (SV) were monitored non-invasively every 5 minutes during operation. 
All recipients also received a prehydration infusion with normal saline (2 ml.kg-1h; 0.9% NaCl) 
from 5 hours preoperatively until the start of operation. Before induction of anesthesia, patients 
received a bolus of colloids (5 ml.kg-1 of HES) during one hour. During the operation, saline was 
administered at 15 ml.kg -1.h-1. A second bolus of colloids was given (5 ml.kg-1) before incision of the skin. 
Each ml blood loss was replaced with colloids (ratio 1:1). All patients received antibiotics, prednisolone 
50 mg, and 50 g mannitol before reperfusion of the kidney. Postoperatively, all recipients received a 
calcineurin inhibitor based on the immunosuppressive regime.
Statistics
Main outcomes were estimated creatinine clearance of donors and recipients during follow-up.  
Donors whose laparoscopic procedure was converted to an open procedure were analyzed in the 
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LDN group according to the intention-to-treat principle. Categorical variables were compared with 
the chi-square test, continuous variables were compared with the Mann-Whitney U test, and repeated 
measurements were compared by repeated measurement of analysis of variance using SPSS mixed 
models; this allowed adjustment for baseline characteristics, including baseline creatinine clearance, 
the donor’s gender and age, and whether or not a transplantation was pre-emptive. All analyses were 
conducted with SPSS (version 11.5, SPSS Inc., Chicago, USA). A p-value <0.05 (two-sided) was considered 
statistically significant.
Results
There were no significant differences in baseline characteristics between the two groups (Table 5.1).  
Two laparoscopic procedures were converted (Table 5.2). One conversion was needed due to 
uncontrolled bleeding from a lumbar branch of the renal vein and one conversion was elective and 
performed immediately after introduction of the camera because of massive adhesions. 
Estimated creatinine clearance of recipients of open and laparoscopic procured kidneys was 
comparable during the 2-year follow-up (Fig. 5.1a and 5.1b). The estimated creatinine clearance of the 
donors was comparable between both groups and remained 35% lower during the 2-year follow-up 
compared with the preoperative values (Fig.5.2). 
Extubation times were similar between donors who underwent ODN and LDN (Table 3).  
No reintubations were necessary. There was no difference in additional oxygen therapy between groups 
during the 2-hour recovery period (Table 5.3). One patient in the LDN group received physostigmine (2 mg) 
for treatment of a central anticholinergic syndrome. In the ODN group, two patients were treated with 
ODN (N=51) LDN (N=59)
Donor
Male gender 19 (37%) 32 (54%)
Age  (years) 50 (21-75) 49 (20-77)
Left kidney 27 (53%) 27 (46%)
ASA classification >I 15 (29%) 11 (19%)
Weight (kg) 75 (48-114) 80 (46-118)
Ideal body weight (kg) 70 (54-98) 75 (55-100)
>1 renal artery 11 (22%) 16 (27%)
>1 renal veins 3 (6%) 5 (9%)
Recipient
Male gender 32 (63%) 32 (54%)
Age   (years) 43 (11-77) 48 (13-73)
Living unrelated recipient 15 (29%) 15 (25%)
Pre-emptive transplantation 11 (22%) 11 (19%)
Data are expressed as number (%) and continuous data as median (range).
Table 5.1. 
Baseline characteristics of the donors and recipients 
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naloxone (0.2 mg) because of respiratory depression caused by sufentanil. 
There were no differences in the complication rates of donors who underwent ODN or LDN 
(Table 5.4). Major complications included an infected wound hematoma in the ODN group requiring 
re-admission and intravenous treatment with antibiotics, and two re-operations in the LDN group. 
Splenectomy was performed in one donor because of persistent bleeding from a tear of the splenic 
capsula, and re-laparoscopy was performed in another donor suspected with continuous bleeding, but 
no bleeding was identified. 
Of all the grafts, 88% produced urine within one hour after re-circulation of the kidney in the 
ODN group, and 95% in the LDN group (Table 5.2). One recipient in each group required dialysis in the first 
Figure 5.1a. 
Estimated creatinine clearance (ml.min-1) with 95% CI of recipients 
the first ten days postoperatively  
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Figure 5.1b. 
Estimated creatinine clearance (ml.min-1) with 95% CI of recipients up to 
two years after donation   
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postoperative week (Table 5.4). In the LDN group, one recipient lost the graft due to arterial thrombosis, 
and another recipient lost the graft due to a severe gynecological infection that was locally spread to 
the transplant. Two grafts were lost in the ODN group due to severe vascular rejections (Table 5.4). 
Biopsy-proven acute rejection occurred more frequently after ODN: 18 versus 10 recipients (Table 5.4). 
Figure 5.2. 
Estimated creatinine clearance (ml.min-1) with 95% CI of living kidney donors over time   
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Table 5.2. 
Intra-operative data of ODN versus LDN 
ODN (N=51) LDN (N=59)
Donor
Conversion to open - 2 (3%)
Time until nephrectomy  (min)
Operation time (min)
108 (60-201)
151 (84-298)
192 (107-339)#
240 (135-390)#
Blood loss  (ml) 200 (20-1400) 110 (10-2700)
Urine production  (ml/kg)
   Pre-operative
   Intra-operative until nephrectomy
1.5 (0.2-3.0)
1.8 (0.5-8.7)
1.6 (0.3-3.6)
1.7 (0.4-5.8)
Recipient
Warm ischemia time (min) 25 (13-165) 27 (12-55)
Urine within one hour 45 (88%) 56 (95%)
Data are expressed as number (%) and continuous data as 
median (range). 
# p < 0.05 between ODN and LDN
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ODN (N=51) LDN (N=59)
Intra-operative data
Sufentanil total (µg/h) 21 (13-36) 23 (13-39)
BIS first 2 hours 44 (35-53) 44 (30-54)
HR first 2 hours 63 (42-90) 63 (86-37)
MAP first 2 hours  (mmHg) 89 (64-123) 94 (52-133)
SV pre  (ml) 81 (38-128) 85 (42-130)
SV first 2 hours  (ml) 84 (35-160) 86 (84-140)
PetCO2 first 2 hours  (kPa) 4.9 (4.2-5.7) 5.2 (4.3-6.2)
Ventilation frequency 12 15
Tidal volume 599 584
PIP 24 26
VCO2 first 2 hours (min/kg)  1.8 (0.9-2.7) 2.5 (1.2-3.6)
PvCO2 after 2 hours (kPa) 5.6 (3.9-7.1) 5.8 (3.9-7)
VO2 first 2 hours (min/kg)  3.1 (2.0-6.2) 3.4 (2.1-6.3)
SaO2 pre 97% (95-100) 97% (94-100)
Postoperative data
Time extubation (min) 24 (2-105) 22 (2-80) 
SaO2 postoperative 2 hours 96% (93-100) 95% (92-100)
Auscultation; number of patients with repitation (%) 0 0
Number of patients needing 
additional oxygen (%) 4 (8%) 6 (10%)
Table 5.3. 
Peri-operative data of ODN versus LDN of the donor  
Data are expressed as number (%) and continuous 
data as median (range). 
# p < 0.05 between ODN and LDN
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Table 5.4. 
Postoperative data of ODN versus LDN 
  
ODN (N=51) LDN (N=59)
Donor
Complications 4 (8%) 3 (5%)
Hospital stay (days) 3 (2-6) 3 (1-10)
Recipient
Dialysis in first week 1 (2%) 1 (2%)
Acute rejection 18 (35%) 10 (17%)
One-year graft survival* 48 (96%) 55 (97%)
One-year recipient survival 50 (98%) 56 (95%)
Two-year graft survival* 48 (96%) 55 (97%)
Two-year recipient survival 49 (96%) 56 (95%)
Data are expressed as number (%) and continuous data as median (range). 
* one- and two-year graft survival censored for death. 
# p < 0.05 between ODN and LDN
Discussion
Although LDN is the preferred method for live kidney donation from the perspective of the  
donor, the results of laparoscopic procurement on early graft function have remained controversial. 
Retrospective analyses of our patient data (patients from 1994 to 2000) 10,11 have shown that 
the estimated glomerular filtration rate (GFR) of donors and recipients was significantly less after 
LDN despite a liberal fluid management (16.2 ml.kg -1.h-1 crystalloids and 3.4 ml.kg -1.h-1 colloids only 
peroperatively). In the donors who underwent laparoscopy, this adverse effect was present up to 
one year, and in the recipients this effect lasted up to 7 days compared with ODN 10,11. Therefore, we 
performed a pilot study in which three different fluid regimes were compared during LDN, including the 
old regime that served as control 22. 
The first group was exposed to overnight fluid infusion and a bolus of colloid before induction 
of anesthesia and before inflation of PP, a second group was exposed to overnight infusion and 
only a bolus of colloid before induction of anesthesia, and a control group that received only fluid 
peroperatively (i.e., the old regime). It was shown that the pre-emptive fluid delivery in combination 
with a fluid bolus given before installation of pneumoperitoneum resulted in less reduction of stroke 
volume and urine output during LDN compared with the control group 22. Fluids administered after the 
installation of PP did not prevent the decrease of stroke volume and decline in urine output during LDN. 
These results emphasize that the total amount of fluid is less important than the timing of 
hydration. Intravascular volume should be expanded before the donor is positioned in the lateral 
position and before installation of PP in order to prevent collapse of the renal veins. 
To investigate whether timed hydration would reduce the clinically experienced differences 
between ODN and LDN, in the present study we applied this new fluid régime in ODN and LDN. With 
adequate prehydration, PP did not cause delayed graft function and did not affect postoperative GFR 
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in the donor. Some have reported slower initial graft function after LDN 4,7,9,10,25 whereas others found 
comparable graft function between LDN and ODN 21,26-28. 
Studies that reported no differences were either comparing hand-assisted laparoscopy with the 
traditional LDN 26 or with ODN 27. Further, these studies did not repeatedly assess renal function during the 
first weeks 21,28,29 or did not adjust serum creatinine values for possible confounders at baseline 21,28,29. 
Most of these studies were retrospectively designed and did not investigate concurrent groups 21,26-28. 
None of these studies had a strict anesthetic protocol or mentioned the fluid regime used. 
Troppmann et al. retrospectively compared 2734 LDN patients with 2576 ODN patients to explore 
the impact of LDN on early graft function; they observed significantly slower early post-transplant graft 
function after LDN 8. Delayed graft function is associated with a higher incidence of acute rejection and 
has been reported to occur more frequently after LDN; even mild to moderate graft dysfunction post-
transplant can have a negative impact on long-term graft survival 8,30,31. 
Proposed mechanisms of delayed graft function after LDN include mechanical injury to the graft, 
longer operation time, longer first warm ischemia time, variable immunosuppression and increased 
abdominal pressure because of PP leading to decreased SV, RBF and GFR 6,12,13,32-34. The predictive 
value of these findings on graft survival remains unclear 35. 
The association between more affected kidney function in donors after LDN, suggests that 
pneumoperitoneum is at least partly responsible for this phenomenon 6. Fluid management is known to 
abolish these changes and could therefore affect kidney function in donor and recipient. Mainly based 
on experimental studies, vigorous hydration up to 2 L.h-1  of crystalloids has been suggested to improve 
preload and diuresis 12. 
Retrospectively, Bergman et al. did not assess differences between groups that received more 
than 10 ml.kg -1.h-1 of fluid intraoperatively and less than 10 ml.kg -1.h-1  crystalloids during LDN. Both 
groups had similar postoperative donor serum creatinine levels, and similar rates of delayed graft 
function and acute rejection in the recipients. The authors concluded that lower intra-operative fluid 
administration did not worsen recipient outcome. However, the delayed graft function was 18% in 
the restrictive fluid group versus 10% in the liberal group 36. In the present study, more fluid was 
administered intra-operatively (13 ml.kg -1.h-1)  crystalloids, and 12 ml.kg-1.h-1  colloids in total) but the 
delayed graft function occurred in only 2% after LDN. 
Our fluid protocol with overnight infusion prehydration may hinder fast-track kidney donation 
and definitely influences the cost of the donation procedure. Perhaps fluids may be given in a shorter 
period and before insufflation of the pneumoperitoneum but further studies needed to investigate this. 
In addition, costs related to additional nights in the hospital by the donor will easily be offset by lower 
rates of delayed graft function.
In conclusion, we found no difference in hemodynamics, urine output and postoperative kidney 
function in donors and recipients between LDN and ODN. This is in contrast to our earlier findings. In 
order to establish that our new fluid regime is responsible for the absence of the delayed graft function, 
a new study is needed in which the old and new fluid regimes are compared directly during LDN. 
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Abstract
Background: Several studies have compared laparoscopic with open abdominal surgery regarding 
the effects on stress responses. Most studies showed lower concentrations of stress hormones after 
the laparoscopic procedure compared to open surgery; however intra-operatively, conflicting results 
were found. It is known that volume status and type of anaesthesia can influence these hormonal 
changes during surgery. Therefore, we studied neuroendocrine stress responses in laparoscopic donor 
nephrectomy (LDN) and open donor nephrectomy (ODN) under propofol anaesthesia compared with 
isoflurane anaesthesia, and using a strict protocol for analgesia and fluid management. 
Methods: A total of 41 LDN patients and 41 ODN patients were included in this prospective 
randomized study. Patients received randomly either propofol or isoflurane anaesthesia. Depth of 
anaesthesia was monitored by the bispectral index. Blood samples for measurement of norepinephrine 
(NE), epinephrine (E), dopamine (DA), vasopressin (AVP), renin (REN), aldosterone (ALD), and glucose 
(GL) were taken before intubation (T1) and before nephrectomy (T2). 
Results: Intra-operatively there were no differences in stress hormone levels between the LDN 
and ODN procedures. During propofol anaesthesia, however, the levels of E (31.7 versus 73.3 pg.ml-1),  
DA (9.3 versus 15 pg.ml-1), AVP (2.5 versus 4.2 pg.ml-1) and REN (2.8 versus 7.5 ngAl.ml-1.h-1) were 
statistically significantly lower compared to those during isoflurane anaesthesia. 
Conclusion: The anaesthetics protocol used resulted in an equal neuroendocrine stress response 
in both LDN and ODN. In addition, in these procedures anaesthesia with propofol resulted in a 
significantly lower level of stress response compared with isoflurane anaesthesia. 
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Introduction 
Surgical procedures are associated with complex stress responses, characterized by 
neuroendocrine, immunologic and metabolic alterations, which are related to the magnitude of 
the inflicted injury 1. Stress response during laparoscopic procedures in supine position (such as 
cholecystectomy) is moderate 2, whereas stress response in lateral decubitus position, in which donor 
nephrectomy is conducted, is significant 3-5. 
Stress response can affect renal function and regulation of body fluid indirectly (as a reflection 
of overall circulatory responses) as well as directly (via intra-renal receptors) 6. CO2 pneumoperitoneum 
(CO2PP) causes a decrease in renal blood flow (RBF) up to 75% of baseline values, with subsequent 
temporary renal ischaemia 7-14, which overall results in extra induction of acute tubular necrosis (ATN) 11-17.  
For kidney donation, where preservation of kidney function is of paramount importance, these 
physiologic changes are undesirable. It has been suggested that kidneys derived with the laparoscopic 
procedure have a higher incidence of delayed graft function in the recipient compared with the open 
procedure 18-20. Moreover Attenuating intra-operative stress is a key factor in improving outcome 21-22. 
Lentschener et al. found that during gynaecological laparoscopic surgery, intra-operative 
haemodynamic and humeral changes did not occur if normovolaemia, adequate depth of anaesthesia, 
and high plasma levels of opiates were maintained 23. Therefore, we were interested in the stress 
response during laparoscopic (LDN) and open (ODN) donor nephrectomy, with the use of our new fluid 
management together with a high dose of opioids. In addition, isoflurane anaesthesia was compared 
with propofol anaesthesia with regard to stress response during these two procedures.
Patients and methods
 
The local human Ethics Committee approved this prospective randomized trial. All patients 
scheduled for donor nephrectomy by the nephrologists and surgeons were eligible for this study, and all 
of them gave written consent. All donors also participated in a study that aimed to determine whether 
LDN or ODN was the preferred operation technique for the living donor 24. 
Randomization was carried out according to a computer-generated list using a hidden block size 
of four. The next numbered sealed opaque envelope provided by the trial statistician was opened when 
informed consent had been confirmed the day before operation. Randomization of the anaesthesia 
group was performed hereafter by the anaesthetists, conducted in similar way. Each operation was 
attended by the same anaesthetist (I.MzB) and surgeons (J.IJ and I.A.); the surgical techniques have 
been described earlier 25. Medication was given according to ideal body weight (IBW), which was 
calculated from a table provided by the local dietician and corresponded to the upper level of normal 
weight as determined by the body mass index. Anti-thrombosis stockings were used routinely to 
improve the venous return peri-operatively.
We used a newly developed fluid regimen, which was equal for all groups 26,27. Pre-operative fluid 
administration was started at 10 p.m. on the day before the operation with Ringer’s Lactate (RL; 3 ml. 
kg-IBW-1 h-1) and continued until the operation. Before induction of anaesthesia, the patients received a 
bolus of colloids (6 ml kg-IBW-1 of 6% Hetastarch 130/0.4), followed by crystalloids (13 ml kg-IBW-1 h-1 RL). 
Before initiation of the laparoscopic procedure (or the open procedure), another bolus of colloids was 
given (6 ml kg-IBW-1 6% Hetastarch 130/0.4). One hour after the start of surgery 20 g mannitol was 
administered. Blood loss was replaced with 6% Hetastarch 130/0.4
Anaesthesia was induced with propofol (2 mg.kg-IBW-1) and sufentanil (0.3 µg.kg-IBW-1). Muscle 
relaxation was achieved with rocuronium (0.8 mg.kg-IBW-1) and monitored by train-of-four (TOF) 
guard, and a bolus of rocuronium (0.3 of mg.kg-IBW-1) was given to keep the TOF under three twitches. 
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Anaesthesia was maintained with propofol by continuous infusion (4–12 mg.kg-IBW-1.h-1), or isoflurane 
(0.5-1.2 % end tidal) maintaining the bispectral index between 40 and 55 (BIS, bispectral index, 
monitor; Aspect Medical Systems, Newton, MA, USA). Analgesia was maintained by continuous infusion 
of sufentanil 0.4µg.kg-IBW-1. h-1 until the kidney was removed. If MAP declined by more than 30% 
from preoperative levels, dopamine was started. These patients were than excluded for the statistical 
analysis of the hormones; norepinephrine (NE), epinephrine (E) and dopamine (DA).  
After intubation, all patients were ventilated in a pressure-controlled mode using a closed-loop 
ventilator (Physioflex®, Dräger, Lübeck, Germany) with the following initial settings: FiO2 of 0.4, positive 
end-expiratory pressure 7 cm H2O, and a peak inspiratory pressure of 22 cm H2O . Ventilation was 
adjusted to keep PetCO2 between 4 and 5.5 kPa, primarily with enhancement of frequency. 
All patients were operated in the lateral decubitus position. Pneumoperitoneum (PP) was 
achieved by insufflation of CO2 with an intra-abdominal pressure of 12 mmHg, which was maintained at 
this level during the operation. 
After positioning of the patient the NICO monitor (Novametrix, Medical Systems Inc., Wallingford, 
CT, USA) was placed between the patient and the ventilator, and an oesophageal Doppler probe 
(HemoSonicTM 100, Arrow International Inc., Reading, PA, USA) was installed. The NICO monitor was 
used to measure the amount of CO2 produced per minute (VCO2); the HemoSonicTM device was used 
to measure stroke volume (SV) every three minutes. Mean arterial pressure (MAP) (measured non-
invasively) and heart rate were extracted every 5 minutes.
Urine output during the donor procedure was quantified. Blood samples of the donors were 
collected to determine creatinine levels the day before operation (Crpre), after induction of anaesthesia 
(CrT1), 6 hours after installation of PP (CrT6), and one day (CrD1) after operation. 
Venous blood samples for measurement of norepinephrine (NE), epinephrine (E), dopamine (DA), 
vasopressin (AVP), renin (REN), aldosterone (ALD), glucose (GL) and PvCO2 were taken after induction 
of anaesthesia but before intubation (sample T1) and two hours after start of the procedure and before 
nephrectomy (sample T2). These samples were collected in chilled heparinized polystyrene tubes.  
All samples were immediately centrifuged at 4°C, and plasma was stored at minus 80°C until analysis. 
NE, E and DA were measured with fluorimetric detection after HPLC separation. Active plasma renin 
activity was measured by radioimmunoassay of angiotensin I formed during incubation in the presence 
of excess exogenous angiotensinogen. AVP and ALD were analyzed by radioimmunoassay using 
commercial kits (DiaSorin, Stillwater, MN, USA and and Diagnostic Products Corporation, Los Angeles, 
CA, USA respectively). Glucose was determined by a standard technique in the Clinical Chemistry 
Laboratory. 
Statistics
The main outcome was the neuroendocrine stress response of the donors between the LDN 
and ODN procedure and secondarily, propofol compared with isoflurane anaesthesia during both 
procedures. Sample size was determined based on literature 23,28. Power calculation had indicated that 
at least 32 patients would be required per group to detect a difference of 20% in plasma concentration 
of NE with an error of 0.05 and a power of 80%. 
Differences between the two operation techniques and between the two anaesthesia techniques, 
demographic data and creatinine levels were compared with two-sided independent Student’s t-test,  
pooled or not pooled, depending on results of Levene’s test, after data were tested for normal 
distribution. Categorical variables were compared with Fisher’s exact two-sided test. Differences 
between neuroendocrine levels were assessed with paired t-tests, and repeated measurements of 
the hormone samples were analyzed by means of SPSS mixed models, which allowed adjustment for 
baseline characteristics. Correlations were determined for BIS value, with MAP and hormone plasma 
levels and for urine output and hormone plasma levels using Pearson’s correlation coefficients. 
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Data are presented as mean values with standard deviation (SD). Statistical analysis was 
performed using SPSS (version 14 SPSS Inc., Chicago, USA). A p-value < 0.05 (two-sided) was considered 
statistically significant. 
Results 
Randomization of the patients scheduled for donor nephrectomy is shown in Figure 6.1. Data 
of the donors were prospectively collected, but for statistical analyses of NE, E and DA, additionally 5 
donors from the LDN group and 2 donors from the ODN group were excluded because these donors 
were given dopamine intravenously. Significantly more DA was used in the isoflurane group (p= 0.03),
Baseline characteristics of the patients are given in Table 6.1; there were no significant 
differences between the subgroups. 
Randomization by the anesthetists
Propofol (N=20)
Propofol (N=19)
LDN (N=43)
isoflurane (N=21)
isoflurane (N=21)
3 patients were not randomized
Propofol (N=19)
Propofol (N=16)
ODN (N=42)
isoflurane (N=22)
isoflurane (N=22)
4 patients were excluded
Donor Nephrectomy (N=85)
Figure 6.1.   
 
A total of 85 patients scheduled for donor nephrectomy, were randomly assigned to the LDN group or the ODN group. 
After this, the patients were stratified to the propofol or isoflurane group. Three patients were excluded because 
the research team was not available, and 4 donors were excluded because the blood collection for neuroendocrine 
hormones failed.
After correction for the baseline levels (T1) of the tested hormones, no differences were found 
between the LDN and ODN group (Table 6.2). In contrast, the hormone levels of E, DA, AVP and REN 
were significantly lower in the propofol group compared to the isoflurane group (Table 6.2). 
Intra-operative data are given in Table 6.3. HR and SV were comparable in all situations, whereas 
MAP was higher in the propofol group. BIS was significantly higher in the isoflurane group (p < 0.001) 
(Table 6.2). No correlation was found between BIS value and MAP and stress hormone plasma levels. 
Until nephrectomy, there was no significant differences in urine output for all groups, except for 
the urine output in the ODN-isoflurane group which was lower the second hour (T2) of operation  
(p = 0.017)(Table 6.3). AVP in the ODN-isoflurane group was significantly higher compared with the 
ODN-propofol group (p = 0.03) (Table 6.2) and correlated with less urine output (p < 0.01). 
 Creatinine levels of the donors were comparable for all groups during the observation period.
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LDN
prop            iso
ODN
prop              iso
p-value 
LDN-ODN
p-value
prop-iso
Gender; male/female 11/8 11/10 4/12 11/11 0.18 0.50
Side kidney; left/right 12/7 11/10 6/10 18/4 0.65 0.17
Weight in kg 78 (16) 80 (17) 73 (17) 79 (16) 0.52 0.33
IBW in kg 74 (10) 74 (13) 70 (11) 75 (13) 0.57 0.50
Age in years 50 (12) 46 (13) 51 (12) 50 (15) 0.43 0.39
Tabel 6.1.   
Characteristics of the patient population (n=77) by subgroup 
 
Data are given as mean (SD)
LDN; laparoscopic donor nephrectomy, ODN; open donor nephrectomy, Prop; propofol, 
Iso; isoflurane, IBW; ideal body weight
                                                                                                                        interaction    interaction 
                                                                                                                           effect             effect 
                                              LDN                                        ODN                   LDN-ODN       prop-iso
                                 prop                 iso                     prop            iso             p-value           p-value 
DAT1 pg.ml-1 5.7 (2.6) 6.5 (4.4) 8.3 (15.6) 6.3 (2.8)
DAT2 pg.ml-1 11.4 (7.1)* 15.5 (13.2)* 7.1 (3.5) 12 (4.5)* 0.056 0.047
NET1 pg.ml-1 125 (50) 197 (109) 132 (87) 164 (91)
NET2 pg.ml-1 110 (60) 243 (200) 113 (92) 183 (154) 0.71 0.081
ET1 pg.ml-1 17 (7) 26 (13) 14 (8) 23 (18)
ET2 pg.ml-1 32 (41) 66 (88)* 31 (32)* 76 (69) * 0.057 0.042
AVPT1 pg.ml-1 4.0 (2.2) 3.5 (1.5) 3.7 (2.2) 3.3 (2.0)
AVPT2pg.ml-1 2.3 (1.6)* 3.2 (2.5) 2.7 (1.7) 5.2 (4.0) 0.054 0.008
RENT1 ngAI.ml-1.h-1 1.8 (1.3) 1.4 (0.6) 1.5 (0.6) 1.7 (0.8)
RENT2 ngAI.ml-1.h-1 3.4 (4.2) 8.3 (8.1) * 2.2 (1.0)* 6.7 (5.8) * 0.22 <0.001
ALDT1 pg. ml-1 43 (41) 36 (29) 31 (27) 28 (28)
ALDT2 pg. ml-1 47 (35) 82 (60) * 73 (68)* 68 (50) * 0.26 0.135
GlucoseT1 mmol. L-1 5.6 (1.0) 5.5 (0.9) 5.5 (0.6) 5.6 (1.0)
GlucoseT2 mmol. L-1 5.7 (1.2) 5.8 (0.8) 5.5 (0.6) 6.2 (1.0) 0.65 0.091
Tabel 6.2.   
Data on hormone levels in the four subgroups. 
Data are given as mean (SD)
* ; p-value < 0.05, for T1 and T2
LDN; laparoscopic donor nephrectomy, ODN; open donor nephrectomy, Prop; propofol, Iso; isoflurane.
DA; dopamine, NE; norepinephrine, E; epinephrine, AVP; vasopressin, REN; renin, ALD; aldosterone
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         LDN           ODN p-value 
LDN-ODN
p-value 
prop-isoProp          iso prop             iso
Prop T0-T2 in mg. kg-1.h-1 6.5 (1.9) 6.5 (1.6) 1.00
Isoet T0-T2  % 0.85 (0.19) 0.86 (0.19) 0.50
Total Suf in ug 122 (29) 131 (27) 98 (19) 107 (27) < 0.001 0.88
Dopamine 0 5 0 2 0.32 0.03
BIS T0-T2 43 (4) 47 (4) 43 (4) 47 (4) 0.40 < 0.001
Blood loss in ml 283 (228) 106 (175) 201 (149) 231 (199) 0.57 0.08
Ext. time in min 22 (20) 24 (19) 21 (31) 31 (27) 0.56 0.30
Haemodynamic parameters
Hr T0-T2 in beats. min-1 63 (9) 62 (13) 62 (11) 64 (10) 0.42 0.38
MAP T0-T2 in mmHg 95 (18) 86 (16) 93 (13) 81 (11)O 0.14 0.001
SV T0-T2 in ml.stroke-1 86 (23) 90 (21) 83 (18) 78 (22) 0.07 0.84
Ventilatory parameters
Vent. Freq T0-T2.per min   15 (3) 16 (3) 11 (3) 13 (3) < 0.001 0.49
Tidal volume T0-T2 in ml   592 (127) 562 (136) 587 (117) 599 (105) 0.52 0.74
PIP T0-T2  in kPa   26 (3) 26 (4) 23 (2) 22 (2) < 0.001 0.86
VO2 T0-T2 in ml. min-1. kg-1   3.3 (0.8) 2.8 (0.4) 2.9 (0.6) 3.2 (1.0) 0.89 0.42
PVCO2T0 in  kPa   6.1 (0.6) 6.0 (0.7) 5.8 (0.9) 6.1 (0.7) 0.63 0.59
PVCO2T2 in  kPa   5.6 (0.7) 5.9 (0.6) 5.7 (0.9) 5.6 (0.6) 0.34 0.64
VCO2 T0-T2 in ml. min-1. kg-1   2.6 (0.5) 2.5 (0.6) 1.9 (0.3) 1.8 (0.4) < 0.001 0.24
Urine output
UOT1 in kg.h -1   2.0 (1.4) 1.6 (1.9) 2.4 (2.1) 1.6 (1.3) 0.77 0.11
UOT2 in kg.h -1   2.3 (1.2) 2.6 (2.1) 2.7 (2.0) 1.4 (0.8) 0.21 0.24
UOTK in kg.h -1   2.2 (1.1) 2.1 (1.8) 2.2 (1.9) 1.6 (0.9) 0.36 0.26
Tabel 6.3.   
Intra-operative data on the four subgroups. 
 
Data are given as mean (SD) 
T0-T2; in the first two hours of operation, PropT0-T2 ; mean use of propofol, Isoet T0-T2 ; mean use of isoflurane (in %), 
Total Suf ; total use of sufentanil in ug (including induction dosage), Dopamine; amount of patients requiring dopamine 
infusion during the operation,  BIS T0-T2 ; mean bispectral index, TK; Operation time, from skin incision until kidney 
extraction, Blood loss; the amount of blood loss until kidney extraction, Ext. time; extubation time, measured from the 
last suture to extubation, HrT0-T2 ; mean heart rate, MAPT0-T2 ; mean arterial pressure,  SVT0-T2 : mean stroke volume,  
PIPT0-T2 ; mean positive inspiratory pressure, VO2 ; mean oxygen delivery, PvCO2T0 ; venous CO2 just before operation, 
PvCO2T2 ; venous CO2 after two hours of operation, VCO2 ; mean CO2 extraction, UOT1 kg.h –1 ; mean urine output, the first 
hour of operation, UOT2 kg.h -1 ; mean urine output, the second hour of operation, UOTK in kg.h -1 ; amount of intra-operative 
urine output until extraction of the kidney.  
74   Neuroendocrine stress responses in laparoscopic and ODN are equal
CHAPTER
6
Discussion
In the present study, intra-operatively there were no differences in stress hormone levels 
between the LDN and ODN procedures. During propofol anaesthesia, however, the levels of epinephrine, 
dopamine, AVP and REN were significantly lower compared with those during isoflurane anaesthesia.
 The present study shows increases during both surgical procedures (although not significant) in 
epinephrine (LDN 22 to 49 pg.ml-1, ODN 18 to 53 pg.ml-1), but not in norepinephrine plasma levels. We 
speculate that the rise in epinephrine in this study is caused by the surgical procedure of nephrectomy, 
which implicates handling of the adrenal gland, which is located next to the kidney. 
No difference in REN and ALD was observed between the LDN and ODN group. This is in contrast 
to earlier findings in which PP resulted in stimulation of the renin-angiotensin-aldosterone system 29-31.  
However, also for REN and ALD there was a moderate and significant rise during both surgical 
procedures (REN; ODN 1.6 to 4.7, LDN 1.6 to 6 ngAI.ml-1.h-1)( ALD; ODN 30 to 70, LDN 39 to 65 pg.ml-1).  
Renal blood flow influences the production of REN and ALD and increases with hypovolaemia, but 
could also be induced through manipulation of the kidney during the procedure, with consequent renal 
vasoconstriction 26,27,32. 
Several studies have reported elevated AVP levels during increased IAP 3,9,16,31,33. AVP regulation 
is influenced by several mechanisms, e.g. osmotic receptors in the hypothalamus, low pressure 
receptors in the atria (via the atrial natriuretic factor) and lung vessels, and high pressure receptors 
in the carotid sinus 34,35. CO2 and mechanical stimulation of peritoneal receptors probably initiate a 
pathophysiologic process that also stimulates AVP release 36. AVP is a potent vasopressor even at 
normal physiologic concentrations 37 and induces reabsorption of water in the distal tubuli resulting 
in less urine production. It has been suggested that increased plasma AVP levels contribute to the 
observed oliguria and elevated MAP during PP 38. In the present study, with the use of our protocol, 
AVP did not increase during either LDN or ODN, it even decreased during the LDN procedure. This 
might implicate that the patients were sufficiently hydrated, that too much elevated intrathoracic 
pressures was sufficiently avoided and that the intra-abdominal pressure elevation of 12 mmHg was not 
enough to release AVP.
An increase in plasma hormones could also be the result of reduced renal clearance and 
glomerular filtration rate, which is known to be reduced during PP 9. In the present study there was an 
equivalent creatinin and urine output during the procedure in all four subgroups, except for the urine 
output in the ODN-isoflurane group. However this only correlated with the AVP plasma level.
In our study epinephrine plasma level in the propofol group during the two procedures was 
less than half of the epinephrine level in the isoflurane group. Also REN and AVP plasma levels were 
significantly lower in the propofol group. 
The impact of propofol on the metabolic hormonal response during surgery has received little 
attention. Our findings of less stress response in the propofol group are supported by the results of 
Ledowski et al. 39. These authors found a higher sympathetic outflow using propofol with remifentanil 
versus sevoflurane with remifentanil during ear-nose-throat surgery; MAP was equal between their two 
anaesthesia groups and the bispectral index was higher in their propofol group. In our study, however, 
MAP was higher in the propofol group and the bispectral index was lower in the propofol group. In 
concordance with Ledowski et al. we found no significant correlation between the bispectral index and 
the release of stress hormones or MAP. In our study a difference in BIS of 43 versus 47 can not explain 
the higher MAP or the lower release in hormones in the propofol group. The lower MAP in the isoflurane 
group might be the reason for compensatory release of hormones. 
Propofol anaesthesia has been shown to attenuate surgical stress-induced adverse immune and 
oxidative stress responses better than other types of anaesthesia 40-43. Although clinical evidence 
is still lacking, some indirect data suggest that the anti-oxidant action of propofol 41,44 might be 
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associated with a more favourable metabolic and immune responses. There is evidence for bidirectional 
communication between the neuroendocrine and immune systems: cytokine production seems to be 
responsible for the development of the stress response of the hypothalamo-pituitary-adrenal axis 
during surgery 45.
Some limitations of our study should be noted. Firstly, as we focused on intra-operative changes 
of neuroendocrine stress hormones we cannot comment on the outcome of our patients. Secondly, 
this study does not clarify whether the derived benefit is due only to the new fluid regimen or to a 
combination of the type of anaesthesia used together with the fluid management. 
The effect of the operation technique on plasma concentrations of epinephrine, dopamine and 
AVP showed no differences with a p-value of < 0.06, suggesting the possibility of a type II error.  
This study was powered for norepinephrine and not for epinephrine, dopamine and AVP.  
Therefore, retrospectively we performed a calculated power analysis based on the assumption that 
mean and SD remains equal and that 20% difference would be of clinical significance. This calculation 
revealed that, if we would have tripled our study groups, still no differences between the two operations 
techniques for plasma concentrations of epinephrine, dopamine and AVP would have been found, with a 
power of 80%. 
We conclude that in both the LDN and ODN group, patients treated with a preload of fluids, under 
general (and monitored) anaesthesia and supplemented with a high dosage of sufentanil, there is only 
a moderate intra-operative stress response, without any differences between operation technique (LDN 
and ODN). Additionally, the choice of anaesthetic drug modifies this response: propofol anaesthesia 
resulted in lower levels of epinephrine, dopamine, AVP and REN for both the LDN and the ODN group, 
compared with isoflurane anaesthesia in donor nephrectomy. 
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Abstract
Background: Laparoscopic surgery for donor nephrectomy is associated with advantages 
such as lower morbidity and shorter convalescent period, advantages that epidural anaesthesia also 
confers. The objective of this study was to evaluate whether epidural analgesia (combined with general 
anaesthesia) would similarly benefit patients undergoing laparoscopic donor nephrectomy (LDN). The 
primary goal was reduced postoperative pain and improved recovery, and the secondary goal was 
kidney function of donor and recipient. 
Methods: Seventy-four patients undergoing LDN were randomised to receive either general 
anaesthesia with sufentanil (GA + Suf) or general anaesthesia in combination with thoracic epidural 
analgesia (GA + TEA). At the end of the operation, a bolus of morphine was administered and the 
epidural catheter was removed. Patients in both groups received patient-controlled (PCA) iv. morphine. 
Postoperative VAS scores for pain, nausea, discomfort and tiredness were recorded. Recovery and 
satisfaction of the donor were evaluated and kidney function by creatinine clearance (CrCl) and urine 
output, were evaluated. 
Results: The patients with epidural analgesia had less pain, experienced less nausea, and 
were more comfortable and satisfied the first hour after extubation. Furthermore, these patients 
were extubated faster and discharged from the recovery room earlier and used less morphine 
postoperatively. Postoperative donor and recipient CrCl values were comparable in both groups.
Conclusion: Epidural analgesia has postoperative advantages for patients undergoing 
laparoscopic kidney donation. These patients benefit from better analgesia, a quicker and smoother 
recovery without influencing postoperative kidney function of the donor and the recipient. 
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Introduction
A smooth perioperative and short convalescent period may motivate more people to consider 
living kidney donation. Kuo et al. reported that 47% of donors donated solely because of the availability 
of the laparoscopic donor nephrectomy procedure and would not have otherwise donated their kidney 1. 
Laparoscopic donor nephrectomy (LDN) is associated with several advantages, such as shorter 
hospitalisation and more rapid convalescence, compared to open donor nephrectomy (ODN) 2.3. 
In abdominal surgery, thoracic epidural analgesia (TEA) improves postoperative outcome and 
attenuates the physiologic response to surgery 4-6. Patients treated with TEA have excellent pain relief, 
a prerequisite for accelerated recovery from surgery, and experience better health-related quality of life 5,6.  
However mid-TEA (Th 6–7) results in a sympathetic block, affecting the autoregulation of the kidney; 
consequently, renal blood flow (RBF) and glomerular filtration rate (GFR) directly depend on mean 
arterial pressure (MAP) and intravascular volume 7. Renal blood flow is already compromised during 
laparoscopic surgery because of increased abdominal pressure during pneumoperitoneum (PP) 8-10.
In this prospective study, by comparing LDN under general anaesthesia with or without 
the combination of epidural analgesia, we investigated whether epidural analgesia benefits direct 
postoperative recovery of living donors. We evaluated remaining donor kidney function and recipient 
kidney allograft function to review the possible renal effects of the epidural technique during LDN. 
Patients and methods
 
The local human ethical committee approved this prospective randomized trial. Written informed 
consent was obtained from all patients. Patients were excluded from the study when the laparoscopic 
approach had to be converted to an open approach, or if the patient wanted to abort the procedure, 
before they arrived in theatre. 
Patients were randomly assigned to general anaesthesia alone (GA + Suf) or to general 
anaesthesia combined with mid-thoracic epidural analgesia (GA + TEA). The night before the operation, 
patients were randomised using sealed opaque envelopes, which the anaesthesiologist opened in the 
presence of the patient. 
Because we chose not to give an epidural to the GA + Suf group, the patients were not blinded to 
the choice of anaesthetic, but they were unaware of the study hypothesis. Blinded observers collected 
postoperative data. Each operation was attended by the same anaesthetist (I.MzB) and surgeons (J.IJ 
and I.A.); the surgical techniques have been described in detail earlier 11. Briefly, the abdomen was 
insufflated with CO2 to a pressure of 12 mmHg. The kidney was extracted through a Pfannenstiel incision 
with an endobag (Endocatch, US Surgical, Norwalk, USA). 
Anaesthesia was induced with propofol (2 mg. kg-IBW-1) and sufentanil (0.3 µg.kg-IBW-1). Ideal 
body weight (IBW) was calculated according to body height, gender, and age. Muscle relaxation was 
achieved with rocuronium (0. 8 mg.kg-IBW-1) and monitored by train of four (TOF) guard, and a bolus 
of rocuronium (0. 3 of mg.kg-IBW-1) was given when necessary to keep the TOF under 3 twitches. 
Anaesthesia was maintained with propofol by continuous infusion (4–12 mg kg-IBW-1. h-1), maintaining 
the bispectral index between 45 and 55 (BIS monitor; Aspect Medical Systems, Newton, MA, USA). In 
the GA + Suf group, analgesia was maintained by continuous infusion of sufentanil 0.4 µg.kg-IBW-1.h-1  
until the kidney was removed. In the GA +EA group, epidural catheter was inserted after locating the 
epidural space with the loss of resistance technique with air at T6-T8 level. This was achieved under 
iv. slight sedation analgesia. A bolus of 8–12 ml (depending on the height of the patient, and our 
clinical experience) of a mixture of 0.25% bupivacaïne with sufentanil (2 µg.ml-1) was given through 
the epidural catheter; after 2 hours an extra bolus of 5–7 ml of the same mixture was given. One hour 
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after the start of operation, 20 g mannitol was administered. At the end of the operation, the GA + Suf 
group received intravenous morphine (0.06 mg.kg-IBW-1), while the GA + TEA group received morphine 
through the epidural catheter (0.03 mg.kg-IBW-1), after which the catheter was removed. 
Epidural analgesia was considered insufficient if heart rate and MAP increased by more than 10% 
after the start of the operation, and an extra bolus of 5–7 ml of a mixture of 0.25% bupivacaïne with 
sufentanil (2 µg.ml-1) did not result in a return to preoperative levels for heart rate and MAP. In this case, 
a continuous infusion of sufentanil was administered (like the GA + Suf group), these patients remained 
in the study group. 
For postoperative pain, both patient groups received intravenous patient control analgesia (PCA) 
with iv. morphine (1mg.ml-1, bolus 1 ml, lock out 5 min). The PCA device was discontinued when the 
patients were tolerating a regular diet or when the patient had not used it the previous 6 hours.  
In both groups, patients started with acetaminophen 1000 mg 4 times a day orally, begun 
preoperatively. Patients received morphine only via the PCA device, and no additional rescue pain 
medication was administered. 
After intubation, all patients were ventilated in a pressure-controlled mode using a closed-loop 
ventilator (Physioflex®, Dräger, Lübeck, Germany) with the following initial settings: 40% oxygen, 
and 60% air, positive end-expiratory pressure 7cm H2O, and a peak inspiratory pressure of 22cm H2O. 
Ventilation frequency was adjusted to keep PetCO2 between 4 and 5.5 kPa. All patients were operated 
in the lateral decubitus position. Pneumoperitoneum (PP) was installed with CO2 with a constant intra-
abdominal pressure of 12 mmHg. 
A strict perioperative fluid management protocol was followed; which consisted of prehydration 
with Ringer’s Lactate (RL) and a bolus of colloids (12 ml.kg-IBW-1 of 6% Hetastarch 130/0.4), before 
initiation of the laparoscopic procedure. Intra operatively crystalloids (13 ml.kg-IBW-1.h-1 RL) were 
administered until nephrectomy, hereafter fluid infusion was adjusted to ensure that exactly 6 hours 
after start of the operation all patients had received in total 
9 ml.kg-IBW-1 h-1 RL. Blood loss was replaced with 6% Hetastarch 130/0.4. This fluid regime was 
investigated in prior studies 12,13. If MAP declined by more than 30% from preoperative levels, dopamine 
was started.
Blood samples were taken from the donor patient to determine creatinine and blood gases at T0 
(before surgery), T2 (2 hours after incision), T6 (6 hours after incision), D1 (first postoperative day), and 
D28 (1 month postoperatively). Creatinine clearance (CrCl) was determined using the Cockcroft-Gault 
formula, which corrects for age, weight and gender 14. Urine output was measured from 10 p.m. the day 
before operation until 6 hours postoperatively. In the recipient, CrCl elevation was measured until one 
month postoperatively. 
A visual analogue score (VAS) concerning pain, fatigue, nausea, and discomfort, and a 
questionnaire consisting of a Mini Mental State Examination (MMSE), was taken preoperatively, and at 
30 and 60 minutes after extubation. VAS was assessed using the 10-cm chiroscience gauge, ranging 
from 0 (indicating no pain, no fatigue, no nausea, or no discomfort at all) to 10 (indicating worst possible 
pain, fatigue, nausea, or discomfort). 
The MMSE, the VAS scores, and the need for supplemental oxygen dictated official discharge 
from the recovery room; this was tested 30 minutes and 60 minutes after extubation. The MMSE score 
should be more than 25, the VAS score for pain and nausea should be less than 4, the VAS score for 
tiredness and discomfort should be less than 6, and oxygen saturation should be more than 95% with 
no more than 2 l.min-1 oxygen supply. A member of the research team blinded to the patient’s group 
assignment conducted interviews. 
Finally, patient satisfaction with the postoperative pain management (using a verbal rating scale 
with 0 = poor to 100 = excellent) was assessed at the patient’s departure from the recovery room 15.  
Use of morphine by the donor patient, VAS for pain and nausea postoperatively. 
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Statistics 
Main outcome was the quality of the direct postoperative period. Power calculation revealed 
that at least 13 donors should be included in each group to detect a difference of 50% in direct 
postoperative pain, with an error of 0,05 and a power of 95% 16. In the computer-generated 
randomisation sequence, 20% extra patients were anticipated in the study group to provide an equal 
number of patients despite expected epidural failures 17. The study was designed as intension to treat. 
Data were analysed using SPSS for Windows (version 14.0) and are presented as means with standard 
deviations (SD). Differences in means between the control and study groups were analysed using 
independent samples t-test, pooled or not pooled depending on results of Levene’s test, this after 
data were tested for normal distribution. Relations between interval- and ratio-levelled variables were 
analysed using Pearson’s correlation coefficient. A p value < 0.05 was considered statistically significant. 
Results 
From August 2004 until January 2006, 143 living-donor nephrectomies were performed 
in our hospital. The donor nephrectomy was performed either by a laparoscopic (N= 99) or by an 
open procedure (N= 44). Of the 99 LDN patients, 18 either were not informed properly during the 
preoperative evaluation (which occurred around 3 months preoperatively) or the complete research 
team was not present during the operation. Another 7 patients refused to take part in the study. 
Finally seventy-four LDN patients gave written consent en were enrolled in the study, of these 
seven patients were excluded, according to our exclusion criteria  (Fig. 7.1). All patients were classified 
as ASA I or II. The characteristics of the two groups were comparable (Table 7.1). 
Operation time (skin-to-skin) and blood loss were significantly shorter in the GA + TEA group 
Scheduled for living donor nephrectomy (N=143)
Epidural (N=42)
No informed consent (N=25)
Laparoscopic Donor Nephrectomy  (N=74)
For inclusion
Open Donor Nephrectomy  (N=44)
No epidural (N=32)
Epidural (N=36)
Epidural catheters 
could not be placed 
: N=2
Patients showed 
insufficient epidural 
analgesia: N=4
No epidural (N=31)
Conversion to open surgery: N=4
patients withdrew themselves from the study, 
before entering theatre: N=2
Conversion to open surgery: N=1
Figure 7.1   
Overview of the study population  
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(Table 7.2). Haemodynamic- and ventilation parameters, sedation level, and amount of propofol used 
were comparable between the groups (Table 7.3). As a result of low blood pressure, four patients 
received dopamine infusion (3-6 µg.kg-1.min-1) as did two patients in the GA + Suf group. Because these 
six patients exhibited significantly higher (r = 0.30; p = 0.014) urine output compared to the group not 
receiving dopamine, these six patients were excluded from statistics for urine output. 
Patients in the GA + TEA group were extubated faster, had less pain, were less nauseated, and 
were more comfortable postoperatively compared to patients in the GA + Suf group; they also had an 
MMSE score 30 minutes after extubation that was similar to their score before the operation, and they 
left the recovery room (p < 0.001) sooner. Fourteen patients in the GA + Suf group indicated to have 
shoulder-tip pain, compared to 2 patients in the GA + TEA group. Patients were tested the moment they 
left the recovery room, and the GA + TEA patients were more satisfied than the GA + Suf patients, with 
their pain management (p < 0.03). In contrast, the GA + Suf patients took longer to wake up and used 
more morphine postoperatively, until two days after the operation (Table 7.4). 
Urine output between groups was comparable from the start of the operation until six hours 
hereafter (mean 1.9 ml.kg1.h-1). In the GA + TEA group, intraoperative and preoperative urine outputs 
were correlated (r = 0.46; p = 0.021), as were intraoperative urine output and MAP (r = 0.43; p = 0.008), 
but not in the GA + Suf group. During PP, CrCl did not decrease. After nephrectomy, CrCl decreased 
equally in both groups (Table 7.5). 
More than 90% of transplanted kidneys from both groups produced urine immediately after 
recirculation. Although the CrCl values of the recipients in the GA + TEA group were higher overall, they 
did not differ significantly between groups at any point in time up to 1 month postoperatively. 
 GA + TEA (N=36) GA + Suf N=31)
Age (yrs) 50 (17) 52 (13)
Weight (kg) 71 (10) 74 (11)
IBW (kg) 69 (8) 71 (9)
BMI (kg.m-2) 24 (4) 26 (5)
ASA I 27 24
ASA II 9 7
Gender  Male 13 7
               Female 23 24
Donor side Left 14 10
                    Right 23 21
Antihypertensive drugs 4 3
Tabel 7.1 
Patient characteristics 
IBW: ideal body weight, calculated according to body height, gender and age
BMI: body mass index
number of patients using antihypertensive drugs (all b blockers)
Data are given as; mean (SD), no significant differences between groups. 
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Tabel 7.2 
Perioperative data: surgery 
 GA + TEA(N=36)
GA + Suf
(N=31) p value 
Warm ischemia (min) 5.5 (3.0) 5.8 (2.9) NS
Blood loss (ml) 101 (101) 174 (164) 0.02
Difference between operation time and time in theatre (min) 73 (19) 62 (14) 0.01
Operation time (min) 210 (50) 231 (52) 0.02
Time for kidney extraction (min) 173 (51) 186 (50) NS
Warm ischemia time: the time of renal artery occlusion, before the kidney is extracted and 
flushed with iced perfusion fluid 
Blood loss: the amount of blood loss until kidney extraction
Operation time: the skin-to-skin operation time in minutes
The time in minutes needed to extract the kidney, from the start of the operation
NS: non-significant
Data are given as mean (SD)  
Tabel 7.3 
Perioperative data: anaesthesiology 
 
GA + TEA
(N=36)
GA + Suf
(N=31)
GA + TEA
(N=36)
GA + Suf
(N=31)
HrT0-T2 66 (10) 64 (10) BIST0-T2 41 (4.5) 40 (4.7)
MAPpre 104 (11) 103 (13) PvCO2T0 5.7 (0.7) 5.7 (0.7)
MAPT0-T2 94 (18) 100 (17) PvCO2T2 6.6 (1.4) 6.3 (0.9)
SVT0-T2 97 (27) 99 (25) PropT0-T2 7.7 (2.0) 7.4 (2.7)
PetCO2T0-T2 5.3 (0.4) 5.3 (0.5) Total Suf 33 (6) 122 (29)
UOT0-2 2.4 (1.6) 2.1 (1.3)
UOT3-6 1.7 (0.9) 1.7 (0.7)
HrT0-T2 :  mean heart rate during the first two hours of operation
MAPT0-T2 :  mean arterial pressure during the first two hours of operation in mmHg
SVT0-T2 :  mean stroke volume during the first two hours of operation in ml
PetCO2T0-T2 :  mean end tidal CO2 during the first two hours of operation in kPa
UO:  urine output in the first two hours (T0-2) or in the third till sixth hour (T3-6) after the incision, in ml kg-1 h-1.
BIST0-T2 :  bispectral index during the first two hours of operation
Above parameters were all measured every 5 minutes
PvCO2T0 :  venous CO2 in kPa, just before operation
PvCO2T2 :  venous CO2 in kPa, after two hours of operation
PropT0-T2 :  use of propofol in mg.kg-IBW
-1 during the first two hours of operation
Total Suf :  total dose of sufentanil given during the procedure in µg
Data are given as mean (SD), if p-value is not given it is non significant
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 GA + TEA(N=36)
GA + Suf
(N=31) p value 
VAS for pain (0–10)
Preoperative 0 (0.1) 0.2 (0.4) NS
Postoperative
30 min 2.3 (2.5) 3.2 (1.4) NS
60 min 2.7 (2.6) 4.5 (2.4) 0.005
day 1 2.9 (1.9) 3.2 (2.5) NS
VAS for tiredness (0–10)
Preoperative 1.0 (1.7) 1.3 (1.6) NS
Postoperative
30 min 3.0 (3.0) 6.8 (2.3) < 0.001
60 min 3.0 (3.1) 5.0 (2.3) 0.032
VAS for nausea (0–10)
Preoperative 0.1 (0.3) 0.2 (0.5) NS
Postoperative
30 min 0.3 (0.1) 1.9 (2.0) < 0.001
60 min 0.7 (1.3) 1.8 (1.7) < 0.001
day 1 2 (2.9) 3.8 (3.4) 0.007
VAS for discomfort (0–10)
Preoperative 1.0 (2.0) 1.5 (2.4) NS
Postoperative
 30 min 2.3 (2.7) 4.7 (2.4) 0.001
 60 min 2.4 (2.6) 4.2 (2.0) 0.007
MMSE (0-30)
Preoperative 28.9 (0.9) 28.5 (1.6) NS
Postoperative
 30 min 26.8 (5.2) 22.7 (6.5) < 0.001
 60 min 28.3 (3.6) 27.0 (3.9) 0.019
Postoperative
Extubation time in min. 15.8 (22.3) 26.2 (26.7) 0.002
Number donors 30 min post-extubation who could not 
be discharged from the recovery care 8 29 < 0.001
Patient satisfaction with pain management (0–100) 
on the moment of recovery discharge 96 85 (15) 0.01
Morfine (mg) used by PCA, day 1 10 (10) 19.7 (14.1) 0.003
Morfine (mg) used by PCA, day 2 0 9.3 (9)
Tabel 7.4
Postoperative results 
VAS: Visual analogue scale rating from 0–10; MMSE: Mini Mental State Examination 
Data are given as mean (SD)
NS: nonsignificant
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Discussion 
This study shows that patients for donor nephrectomy benefit from epidural analgesia in the 
postoperative period (reduced pain, improved and faster patient recovery). Laparoscopic surgery has 
become popular because of its smooth and fast recovery; however, in the immediate postoperative 
period, pain in the laparoscopic patient can be as severe as for laparotomy 18,19, and nausea is a primary 
complaint. Our observations confirmed these findings: the patients in the GA + Suf group had a mean 
VAS of 4.5 one hour after extubation, although relative high dosage of sufentanil was given during the 
operation. 
Epidural analgesia has been reported to significantly reduce perioperative morbidity, including 
ileus, acute renal failure (approximately 30%), and blood loss (approximately 30%). Epidural analgesia 
not only improves analgesic efficacy but also reduces opioid demand and side effects such as nausea, 
vomiting, and sedation 5,6,20. The results of the present study confirm this finding. 
Combined spinal–epidural anaesthesia for traditional open donor nephrectomy, compared to 
general anaesthesia, results in lower morbidity and shorter hospitalisation, with similar effects on 
kidney graft function in recipients and the remaining kidney function of the donors 21,22.
The use of TEA for laparoscopic procedures is becoming more common. However for the 
laparoscopic cholecystectomy TEA was not recommended in a recent review from Bisgaard et al. 23. 
In colon surgery, TEA significantly improves early analgesia and favourably affects dietary tolerance 
and duration of stay 24,25. However, in other studies, epidural analgesia is one item in a multimodal 
rehabilitation program 26,27, and it is not clear that epidural analgesia is the sole reason for the success. 
To decide whether GA+TEA with single shot morphine is the better treatment for the LDN procedure, 
a risk benefit analysis should be done. Risks (in a general population) are e.g.; spinal haematoma 
(incidence 1:150.000), serious infections (1:10.000), late respiratory depression (5:1000), nausea (3:10) 
and purities (6:10) 28. Most of these risks are related to morphine dosage, duration of catheter insertion 
and underlying health of the patients 28. The incidence of these risks will be much lower in the healthy 
donor population, and with the low dosage of morphine as we used. Besides in this study none of 
these side effects were encountered. In addition the procedure of catheter insertion can be painful 
and bothersome, however this was done under sedation and our protocol dictated that the procedure 
Tabel 7.5
Perioperative CrCl values, from the donors
GA + TEA (N=36 GA + Suf (N=31)
CrCl pre 98 (30) 102 (24)
CrCl T0 116 (39) 114 (30)
CrCl T2 120 (40) 122 (28)
CrCl T6 90 (28) 94 (20)
CrCl D1 67 (20) 71 (15)
CrCl calculated with the Cockroft-Gault formula
pre: preoperative CrCl
T0: CrCl just before surgery
T2: CrCl two hours after start of surgery
T6: CrCl six hours after start of surgery, which is about 2.5 hours after the end of surgery
D1: CrCl one day after surgery
Data are given as mean (SD); there were no significant differences between groups.
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for epidural placement should be swift and smooth; if not the procedure was boarded. In the end the 
patients scored satisfaction with pain management and they scored all the maximum of 100, except for 
the group who had to be converted intra-operatively to the sufentanil regime.  We used in the GA+Suf 
group high dosage of sufentanil (mean 122 µg), this to assure stress free anaesthesia. If we had used 
lower amounts of sufentanil the differences in postoperative pain and discomfort would presumably be 
greater. 
Than the risk of renal function impairment due to TEA should be addressed. Regional anaesthesia 
and the kidney interact in a complex manner, renal blood flow and filtration fraction can be influenced 
both directly and indirectly by underlying cardiovascular function, fluid status and the level of induced 
sympatholysis in the patient. Regional anaesthesia from level T4 reduces or even abolishes sympathetic 
tone to the kidney, accordingly auto-regulation of renal blood flow (RBF) and glomerular filtration rate 
(GFR) is lost (mainly the efferent vasoconstriction is blocked which results in a lower filtration fraction), 
this makes RBF and filtration directly dependent on mean arterial pressure (MAP) and intravascular 
volume 7,29. Laparoscopic surgery is normally associated with reduced RBF and GFR. A series of 
systemic and renal compensatory responses during elevated intra-abdominal pressure are activated 
to preserve ultrafiltration and renal clearance. Normally cortical-to-medullary redistribution of RBF 
protects the vulnerable medullary oxygen balance 30. Iwase et al. determined the serial changes in renal 
function occurring during laparoscopic cholecystectomy; they showed that the decrease in GFR during 
pneumoperitoneum (PP) was less pronounced than that in RBF, which means that the filtration fraction 
was enhanced 31. In the present study, we observed a MAP of 100 mmHg in the GA + Suf group and a 
MAP of 94 mmHg in the GA + TEA group. Urine output was closely related with MAP in the GA + TEA 
group, and the intraoperative urine output correlated with preoperative urine output, an association 
not seen in the GA + Suf group. In this study, CrCl did not decline during PP in either group, not even 
in the GA + TEA group where sympatholysis blocked autoregulation and the filtration fraction could 
not be enhanced, implying that MAP and intravascular volume were sufficient. In a study of healthy 
volunteers from Suleiman et.al., renal blood flow was unchanged during epidural anaesthesia with a 
T6 sensory block as long as MAP remained higher than 70 mmHg and did not decrease more than 6% 
below baseline level 32. If GFR and urine output do not decrease, as in the present study, the cautious 
implication can be, that RBF was not compromised during PP or because of TEA. 
We chose to remove the epidural catheter at the end of the operation in this study, after 
administration of a bolus of morphine (0.03 mg.kg-IBW-1) via the catheter. Viscusi et al. concluded in 
their review that a single epidural injection of morphine for postoperative analgesia can be a favourable 
technique 33. For practical reasons (e.g., no experience on the ward with this regime and reduction 
of side effects), in our previous pilot study we started with a low dosage of epidural morphine bolus. 
This dosage of (0.03 mg.kg-IBW-1) proved to be sufficient in reducing the specific postoperative pain 
(shoulder-tip pain) after laparoscopy. Our previous clinical experience had shown that continuous 
epidural analgesia postoperatively, did not improve VAS scores for pain and nausea one day after LDN, 
but it did delay removal of the urine catheter and mobilization of the patient. 
Our study had some limitations. Epidural analgesic function was not tested before operation, but 
failure was anticipated based on hemodynamic data.  In addition, the GA+Suf group did not receive a 
sham epidural catheter. Although the widely used Cockcroft-Gault formula for estimation of CrCl is a 
crude measure of renal function, we chose to use this approach instead of more advanced methods 
(like inulin clearance for GFR and para-aminohippurate clearance for RBF). This because we were mainly 
interested in the trend and the comparison between the two groups, not in the absolute values, and 
as long the patients are not too old or too obese it is an acceptable estimation 34. These were chooses 
the study team made, because the study should not be unnecessary demanding to the donor. Another 
limitation associated with a study involving epidural analgesia is the procedure for placing the epidural 
catheter. The anaesthetist residents who were part of the research team placed most of the catheters, 
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and although under close supervision, our epidural failure rate was 15%. Still the failure rate in the 
current study is in line with the 12 to 13% reported overall, and the up to 22% reported for teaching 
hospitals 17,35. 
The epidural approach as used in this study showed advantages for patients undergoing 
laparoscopic kidney donation in the postoperative period: the patients benefit from a quicker and 
smoother recovery and were more satisfied with their pain management. With the perioperative 
fluid management protocol used in this study, TEA did not result in a compromised postoperative 
kidney function in the donor or the recipient. Use of TEA for patients in whom renal performance is of 
utmost importance (as it is in this study group) should be done with special care to maintain adequate 
intravascular volume and MAP, especially because laparoscopic surgery is normally associated with 
reduced renal blood flow and GFR. These results are particularly interesting because a quicker and 
smoother recovery for kidney donors may be paramount in motivating eligible donors.
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Abstract 
Introduction: Pneumoperitoneum created during laparoscopic donor nephrectomy (LDN) 
negatively affects renal hemodynamics through renal vein compression and activation of the neuro-
humoral stress response. We hypothesized that the thoracic epidural blockade attenuates hormone 
responses in donors undergoing LDN.
Patients and Methods: Between 2004 and 2006, we randomised 61 LDN patients into two 
groups: 31 patients received general anaesthesia (GA + Suf), while 30 patients received general 
anaesthesia combined with an epidural analgesia (GA + TEA). Fluid regime, ventilation, and anaesthetic 
management were standardized. Venous blood was sampled for measurements of epinephrine, 
norepinephrine, dopamine, renin, aldosterone, cortisol, C-reactive protein and creatinine, before, during 
and after operation. 
Results: Norepinephrine (p= 0.004), cortisol (p = 0.02) and C-reactive protein (p= 0.007) 
responses were significantly lower in the study group compared to control. Creatinine concentration did 
not differ between both donor groups or the donor recipients of these groups. 
Conclusion: Thoracic epidural analgesia depresses the neuroendocrine stress and the 
postoperative inflammatory response more than high dosage of sufentanil during LDN. 
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Introduction: 
Surgical procedures are associated with a complex stress response mediated by endocrine 
metabolic changes and biological cascades that include the C-reactive protein (CRP) 1. 
Compared to open donor nephrectomy (ODN), laparoscopic donor nephrectomy (LDN) is 
associated with a shorter and less intense recovery phase for the donor 2-3. However, despite the 
improved conditions for recovery, the stress response during LDN is still shown to be significant 4,5. 
The pneumoperitoneum (PP) necessary for LDN is known for its adverse hemodynamic and renal 
physiology. The increased intra-abdominal pressure (IAP) causes a decrease in renal blood flow (RBF), 
glomerular filtration rate (GFR), and urine output conducted through compression of the renal veins, as 
well as activation of the sympathetic and humoral vasoactive system 6-8. Literature shows that kidneys 
derived with the laparoscopic procedure show a higher incidence of delayed graft function in the 
recipient compared with those obtained from the open procedure 9-11. 
In abdominal surgery, thoracic epidural anaesthesia/analgesia (TEA) with local anaesthetic 
agents improves postoperative outcome via beneficial effects on organ function 1,12-14.  
Epidural local anaesthetics providing an effective afferent blockade results in inhibition of the classical 
stress and inflammatory response normally induced by surgery such as; catecholamines, cortisol, 
glucose and CRP 13. This stress response also affect the kidney and its blood flow. 
For kidney donation, preservation of kidney function and smooth recovery of the donor are 
of paramount importance. In a prior study we already proved that the use of TEA has postoperative 
advantages for patients undergoing LDN 15. These patients benefit from a quicker and smoother 
recovery without influencing postoperative kidney function of the donor and the recipient.
In this prospective study, our objective was to compare the effects of our previous high dosage 
sufentanil regime to TEA in relation to neuroendocrine stress and systemic inflammatory response in LDN. 
 
Patients and methods 
This study was approved by the local human ethics committee, and written informed consent was 
obtained from all patients. Data of the same patient group were used in a parallel study 15. Patients were 
excluded from the study if the laparoscopic approach had to be converted to an open approach, if the 
patient chose to abort the procedure, and when epidural analgesia failed. 
Patients were randomly assigned either to general anaesthesia (GA + Suf) or to general anaesthesia 
combined with mid-thoracic epidural analgesia TEA (GA + TEA). The night before the operation, patients 
were randomised using sealed opaque envelopes, which the anaesthesiologist opened in the presence 
of the patient. Because we chose not to give an epidural to the control group, the patients were not 
blinded to the choice of anaesthetic, but they were unaware of the study hypothesis. Blood samples for 
analyses were not labelled according to treatment group and were analysed by a blinded technician; the 
results of the tests were revealed only after the last patient was included. 
In the GA +TEA group, epidural catheter was inserted after locating the epidural space with the loss 
of resistance technique with normal saline at T6-T8 level. This was performed, according to standard 
procedures from our hospital. To ensure a comfortable and stress-free situation for the patients, the 
donors were allowed to stop the procedure on their own accord, and the duration of the procedure  
was restricted. 
Ideal body weight (IBW) was calculated according to body height, gender, and age.
Anaesthesia was induced with propofol (2 mg.kg-IBW-1) and sufentanil (0.3 µg.kg-IBW-1). Muscle 
relaxation was achieved with rocuronium (0.8 mg.kg-IBW-1) and monitored by train of four (TOF) guard, 
and a bolus of rocuronium (0.3 of mg. kg-IBW-1) was given when necessary to keep the TOF under three 
twitches.  
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Anaesthesia was maintained with propofol by continuous infusion (4–12 mg.kg-IBW-1.h-1), maintaining the 
bispectral index between 45 and 55 (BIS monitor; Aspect Medical Systems, Newton, MA, USA).  
In the GA + Suf group, analgesia was maintained by continuous infusion of sufentanil (0.4 µg.kg-IBW-1.h-1) 
until the kidney was removed. In the GA + TEA group, a bolus of 8–12 ml (depending on the height of the 
patient, and our clinical experience) of a mixture of bupivacaïne (0.25%) with sufentanil (2 µg.ml-1) was 
given through the epidural catheter; after two hours, an extra bolus of 5–7 ml of the same mixture was 
administered. At the end of the operation, the GA + Suf group received intravenous morphine (0.06 
mg.kg-IBW-1), while the GA + TEA group received morphine through the epidural catheter (0.03 mg.kg-
IBW-1), after which the catheter was removed. Epidural analgesia was considered insufficient if heart 
rate and MAP increased by more than 10% after the start of the operation, and an extra bolus of 5–7 ml 
of a mixture of 0.25% bupivacaïne with sufentanil (2 µg.ml-1) did not result in a return to preoperative 
levels for heart rate and MAP. In this case, a continuous infusion of sufentanil was administered (like 
the GA + Suf group) and the patient was excluded from the study. For postoperative pain, both patient 
groups received intravenous patient control analgesia (PCA) with morphine (1mg.ml-1, bolus 1 ml, lock 
out 5 min). In both groups, patients started with acetaminophen (1000 mg, 4 times a day orally), which 
begun before the operation. 
 After intubation, all patients were ventilated in a pressure-controlled mode using a closed-loop 
ventilator (Physioflex®, Dräger, Lübeck, Germany) with the following initial settings: 40% oxygen 
and 60% air, positive end-expiratory pressure of 7 cm H2O, and a peak inspiratory pressure of 22 
cm H2O. Ventilation frequency was adjusted to keep PetCO2 between 4 and 5.5 kPa. The closed-loop 
ventilator provided the oxygen delivery in ml.min.kg-1 (VO2 kg
-1): All patients were operated in the lateral 
nephrectomy position. After positioning of the patient an oesophageal Doppler probe (HemoSonicTM 
100, Arrow International Inc., Reading, PA, USA) was placed this device was used to measure stroke 
volume (SV) every three minutes. Mean arterial pressure (MAP) and heart rate were extracted every 
three minutes. 
PP was installed with CO2 with a constant intra-abdominal pressure of 12 mmHg. 
Peri-operative fluid management was as follows: pre-operative fluid administration of 3 ml.kg-
IBW-1.h-1 Ringer’s Lactate (RL) was initiated at 10 p.m. on the day before the operation until the 
operation, 11 hours later. Prior to induction of anaesthesia, the patients received a bolus of colloids  
(6 ml.kg-IBW-1 of 6% Hetastarch 130/0.4), followed by crystalloids (13 ml.kg-IBW-1 h-1 RL). Before initiation 
of the laparoscopic procedure and after the first blood sample (T0), another bolus of colloids was given 
(6 ml.kg-IBW-1 6% Hetastarch 130/0.4). Blood loss was replaced with 6% Hetastarch 130/0.4. After 
nephrectomy, the infusion protocol was adjusted to ensure that exactly 6 hours after the start of the 
operation all patients had received a total of 9 ml.kg-IBW-1.h-1 RL. This fluid regime was investigated in 
prior studies 16,17. If MAP declined by more than 30% from preoperative levels, dopamine infusion was 
initiated. One hour after the start of the operation, 20 g mannitol was administered.
Venous blood samples were taken from the donor patient to determine creatinine and hormone 
concentrations (epinephrine (E), norepinephrine (NE), dopamine (DA), renin (REN), aldosterone (ALD), 
cortisol (COR)) at T0 (after induction of anaesthesia but before intubation and surgery), T2 (2 hours 
after incision), T6 (6 hours after incision), D1 (first postoperative day) and D28 (1 month postoperative). 
These samples were collected in chilled heparinized polystyrene tubes. All samples were immediately 
centrifuged at 4°C, and plasma was stored at minus 80°C until analysis. NE, E and DA, were measured 
by fluorimetric detection after HPLC separation. Active plasma renin activity was measured by 
radioimmunoassay of angiotensin I formed during incubation in the presence of excess exogenous 
angiotensinogen. The serum concentration of cortisol was determined by competitive luminescence 
immunoassay (ACS: centauer, Bayer Diagnostics, Mijdrecht, the Netherlands). C-reactive protein (CRP) 
was measured at D-1 (one day before operation) and on days 1 to 3 after operation (D1-D3). Serum CRP 
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was measured using an immunoturbidimetric assay (Boehringer, Mannheim, Germany) with a minimum 
detectable concentration of 0.3 mg.dl-1.
Urine output was measured from 10 p.m. the day before operation until 6 hours after operation. 
Creatinine concentrations were measured till 3 days postoperative in de donors and till one month 
postoperative in the recipients of the donor kidneys.
 
Statistics
The main outcome was the neuroendocrine stress response during LDN with two different 
anaesthesia techniques. Sample size was determined based on literature 18. Power calculation had 
indicated that at least 29 patients would be required per group to detect a difference of 25% in 
plasma concentration of Cortisol with an error of 0.05 and a power of 80%.In the computer-generated 
randomization sequence, 20% extra patients were anticipated in the study group to provide an equal 
number of patients despite expected epidural failures 19. Data were analyzed using SPSS for Windows 
(version 14.0 Inc., Chicago, USA) and are presented as means with standard deviations (SD). After data 
were tested for normal distribution, differences in means between the GA + Suf and GA + TEA groups 
were analysed using independent samples t-test, pooled or not pooled depending on the results of 
Levene’s test. Categorical variables were compared with Fischer’s exact two-sided test. Differences 
between the stress hormone concentrations over time and between the two different anaesthesia 
techniques were assessed using SPSS linear mixed models with Bonferroni correction. This allowed for 
adjustment of baseline characteristics at T0, and the “drop out hormone levels” of certain time points 
(T2, T6 or D1) did not result in the deletion of the hormone data for T0, T2, T6 or D1. Hormone pair-wise 
comparison was performed between the control group and study group, and over time. A p value < 0.05 
was considered statistically significant. 
Results
From August 2004 until January 2006, 143 living related kidney donations were performed at 
our institution. Donor nephrectomy was performed either by a laparoscopic (N= 99) or by an open 
procedure (N= 44). Of the 74 LDN patients who gave informed consent to participate in the study, two 
patients later withdrew their consent, and 11 patients were excluded, according to our exclusion criteria 
(Fig 8.1), leaving a total study population of 61 patients. Thirty patients were randomized to the  GA + 
TEA group, and 31 patients to the GA + Suf group. All patients were classified as ASA I or II. The patient 
characteristics of the two groups were comparable (Table 8.1).  
Four patients in the study group and 2 patients in the control group required dopamine 
infusion (3-6 µg.kg-1.min–1) to maintain an adequate MAP. In these patients, data regarding hormone 
concentrations of NE, E, DA and urine output were excluded, as these variables are directly influenced 
by dopamine. 
Norepinephrine and cortisol responses to LDN were significantly lower in the GA + TEA group 
compared to the GA + Suf group. Also, the C-reactive protein response was suppressed in the GA + TEA 
group compared to GA + Suf group (Figs. 8.2, 8.3, 8.4). Epinephrine, dopamine, renin, and aldosterone 
concentrations were comparable between both groups (Table 8.4). Hemodynamic and ventilatory 
variables, were comparable between both groups (Table 8.3). Intra-operative urine output was slightly 
higher in the GA + TEA group, though not to a significant degree, and creatinine concentrations for the 
donors and the recipients were comparable.
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Epidural (N=42)
Laparoscopic Donor Nephrectomy  (N=74)
For inclusion
No epidural (N=32)
Epidural (N=30) No epidural (N=31)
Conversion to open surgery: N=4
Patients who withdrew themselves from the study: N=2
Inability to place the epidural catheters : N=2
Patients showing insufficient epidural analgesia: N=4
Conversion to open surgery: N=1
 GA +TEA (N=30) GA +Suf (N=31)
Age (yrs) 49 (17) 52 (13)
Weight (kg) 71 (11) 74 (11)
IBW (kg) 69 (8) 71 (9)
BMI (kg.m-2) 24 (3) 26 (5)
Male 10 7
Female 20 24
Donor side left 11 10
Donor side right 19 21
Antihypertensive drugs 0 3
Tabel 8.1 
Patient characteristics 
IBW: ideal body weight, calculated according to body height, gender and age
BMI: body mass index
number of patients using antihypertensive drugs (all ß blockers)
Data are given as mean (SD). No significant differences were detected between groups.
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 GA +TEA (N=30) GA +Suf (N=31) p value 
Warm ischemia (min) 5.7 (3.2) 5.8 (2.9) NS
Blood loss (ml) 94 (97) 174 (164) 0.016
Time before incision (min) 61 (13) 50 (11) 0.002
Operation time (min) 202 (40) 231 (52) 0.017
Time for kidney extraction (min) 165 (43) 186 (50) NS
Tabel 8.2 
Intra operative data
Warm ischemia time: the time of renal artery occlusion before the kidney is extracted and 
flushed with iced perfusion fluid
Blood loss: the amount of blood loss until kidney extraction
Operation time: the skin-to-skin operation time in minutes
Time for kidney extraction: The time in minutes needed to extract the kidney from the start of the operation.
NS: nonsignificant
Data are given as mean (SD). 
 GA +TEA (N=30) GA +Suf (N=31)   GA +TEA (N=30) GA +Suf (N=31)
HrT0-T2 66 (11) 64 (10)  pHT0 7.38 (0.04) 7.39 (0.04)
MAPpre 102 (10) 103 (13)  pHT2 7.33 (0.04) 7.32 (0.05)
MAPT0-T2 92 (19) 100 (17)  PvCO2T0 5.7 (0.7) 5.7 (0.7)
SVT0-T2 96 (28) 97 (25)  PvCO2T2 6.7 (1.5) 6.3 (0.9)
PetCO2T0-T2 5.3 (0.4) 5.3 (0.5)  BIST0-T2 41 (4.4) 40 (4.7)
VF 18 (3.3) 18 (3.5)  PropT0-T2 7.7 (2.1) 7.4 (2.7)
PIP 24 (3) 25 (2)  Dopamine 4 2
VO2 kg-1 3.5 (1.1) 3.8 (1.3)  Lactate T0 1.4 1.2
UOT0-2 2.42 (1.6) 2.14 (1.34) Lactate T2 1.3 1.2
UOT3-6 1.7 (0.9) 1.7 (0.7)
Tabel 8.3
Perioperative data: anaesthesiology
HrT0-T2: mean heart rate during the first two hours of operation; MAPT0-T2: mean arterial pressure during the first two 
hours of operation in mmHg; SVT0-T2: mean stroke volume during the first two hours of operation in ml; PetCO2T0-T2: mean 
end tidal CO2 during the first two hours of operation in kPa; VF: ventilation frequency; PIP: positive inspiratory pressure; 
VO2 kg
-1: oxygen delivery in ml.min kg-1; pH, just before operation (T0) or after two hours of operation (T2); PvCO: 
venous CO2 in kPa, just before operation (2T0) or after two hours of operation (2T2); BIST0-T2: bispectral index during the 
first two hours of operation; PropT0-T2: use of propofol in mg.kg-IBW
-1 during the first two hours of operation; UO: urine 
output in the first two hours (T0-2) or in the third till sixth hour (T3-6) after the incision, in ml.kg-1 h-1; Dopamine the 
number of patients who were supplemented with dopamine infusion as dictated by our protocol; Lactate in mmol.L-1
Data are given as mean (SD). No significant differences were detected between groups.
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GA +TEA (N=30) GA +Suf (N=31) 1 2
NE pg/ml T0 152 (105) 177 (79) 0.61
NE pg/ml T2 143 (133) 208 (148) 0.21
NE pg/ml T6 278 (202)* 507 (364)** < 0.001
NE pg/ml D1 186 (76) 260 (107)* 0.23
NE pg/ml total 191 294 0.004
E pg/ml T0 22 (14) 18 (8) 0.84
E pg/ml T2 76 (116)* 66 (107)* 0.61
E pg/ml T6 76 (69)** 99 (63)** 0.26
E pg/ml D1 33 (16) 52 (29)** 0.54
E pg/ml total 52 59 0.6
DA pg/ml T0 21 (30) 15 (16) 0.59
DA pg/ml T2 39 (74) 27 (22)* 0.31
DA pg/ml T6 21 (19) 28 (30)* 0.49
DA pg/ml D1 34 (46) 12 (5) 0.11
DA pg/ml total 28 21 0.091
Re ngAl/ml.h T0 270 (212) 192 (97) 0.18
Re ngAl/ml.h T2 458 (354)* 317 (352) 0.017
Re ngAl/ml.h T6 195 (90) 177 (96) 0.77
Re ngAl/ml.h D1 156 (104) 161 (79) 0.95
Re ngAl/ml.h total 270 212 0.089
Ald pg/ml T0 21 (24) 21 (17) 0.99
Ald  pg/ml T2 70 (65)** 51 (49)* 0.1
Ald  pg/ml T6 59 (60)* 50 (43)* 0.44
Ald pg/ml D1 28 (29) 42 (41)* 0.27
Ald pg/ml total 44 42 0.72
Cort nmol/L T0 430 (170) 481 (132) 0.093
Cort nmol/L T2 361 (268) 485 (235) 0.059
Cort nmol/L T6 607 (323)* 689 (320)* 0.82
Cort nmol/L D1 495 (231) 651 (209) 0.087
Cort nmol/L total 483 580 0.02
CRP mg/ml D-1 3 (2) 11 (5) 0.5
CRP mg/ml D1 53 (23)** 66 (38)** 0.29
CRP mg/ml D2 74 (35)** 125 (86)** < 0.001
CRP mg/ml D3 60 (31)** 96 (65)** 0.006
CRP mg/ml total 47 75 0.007
Tabel 8.4
Hormone concentrations
1. p-value linear mixed models with Bonferroni correction 
2. Differences in groups, pair wise comparison. 
 epinephrine (E), norepinephrine (NE), dopamine (DA), renin (REN), aldosterone (ALD), cortisol (COR) and C-reactive 
protein (CRP); T0: just after induction of anaesthesia, but before intubation and surgery; T2: 2 hours after start of the 
operation; T6: 6 hours after start of the operation; D-1: day before the operation; D1: day 1 after the operation      
Data listed as mean (SD).
* p < 0.05 compared with T0, or D-1; ** p < 0.001 compared with T0, or D-1
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Discussion
In this clinical study, we demonstrated that additional use of TEA did suppress plasma 
concentrations of norepinephrine and cortisol in donors undergoing laparoscopic donor nephrectomy 
(LDN); in contrast, epinephrine, dopamine, renin, and aldosterone release remained unaffected. The 
reduced plasma norepinephrine concentrations, probably is a direct result of the sympaticolythic 
effect of the local anaesthetics. But the GA + TEA group also exhibited suppressed plasma cortisol 
concentrations, indicating an overall stress reduction. In addition C-reactive protein, an inflammatory 
marker, was significantly reduced in the GA + TEA group from the second postoperative day and 
onwards. 
The use of additional TEA for laparoscopic procedures is becoming more common, particularly 
in colon surgery in which TEA significantly improves early analgesia and favourably affects dietary 
tolerance and duration of stay 20,21. The impact of the addition of TEA analgesia to general anaesthesia 
on the metabolic hormonal response during laparoscopic surgery however has received little attention. 
The few publications on this topic are performed for laparoscopic cholecystectomy, they describe 
a reduction in AVP, epinephrine, norepinephrine and cortisol on account of the usage of additional 
epidural analgesia 18,22,23. 
The endocrine metabolic response during and after laparoscopic surgery compared to open 
surgery has been studied by several authors, most of them have been unable to detect an endocrine 
metabolic response increase during PP compared to open surgery, these concerned cholecystectomy or 
gynaecological surgery 13. However, laparoscopic procedures with low amounts of fluid administration 
(< 6 ml kg-1 h-1) or laparoscopic procedures performed in lateral nephrectomy position (in which LDN is 
conducted) have shown increased concentrations of stress hormones 4,5,8,24-28. 
Previously, we demonstrated that the LDN procedure handled with an explicit protocol for 
anaesthesia, with adequate depth of anaesthesia, high dose of opioids and preoperative hydration 
before installation of PP, attenuated the hemodynamic compromise from this PP 16,17. However, the high 
dose of opioids (as part of our multimodal approach) resulted also in longer recovery time. 
0,0
20,0
40,0
60,0
80,0
100,0
120,0
140,0
CRP D-1 CRP D1 CRP D2 CRP D3
GA + Suf
GA + TEA
time
C
R
P
 m
g
.m
l -
 1
*
*
Fig. 8.4
CRP concentrations
 Effect of epidural analgesia on inflammatory and stress response in LDN   103
CHAPTER
8
In abdominal surgery, TEA improves postoperative outcome with less perioperative morbidity, 
resulting in swifter recovery, and attenuates the physiologic response to surgery 12-14,29. Furthermore, 
effective afferent neural blockade with epidural local anaesthetic techniques inhibits a major part of 
the endocrine metabolic response, leading to improved protein economy 13. Combined spinal–epidural 
anaesthesia for traditional ODN, compared to general anaesthesia, also resulted in lower morbidity and 
shorter hospitalisation, with similar effects on kidney graft function in recipients and the remaining 
kidney function of the donors 30,31. 
When using TEA with local anaesthetic, it has to be considered that the induced sympathicolysis, 
might result in  relative hypovolemia. The LDN procedure is already prone for relative intra-abdominal 
hypovolemia through the lateral nephrectomy position and the mechanical compression during PP.  
Hypovolemia with a reduction in renal blood flow (RBF), will cause stimulation of the RAAS (renin-
angiotensin-aldosterone system) 6,8,26. We used a fluid regime with the aim of preventing RBF reduction 
based on PP 16,17. In addition we aimed with our sympathiclysis at the operation area only, by placing 
the epidural catheter between Th 6 and 7, and by administration of a relative small amount of local 
anaesthetic. In the present study SV and urine output were equal between the two groups, however the 
plasma concentration of REN was significantly higher at T2 (when the laparoscopic procedure was  
2 hours in progress). This might indicate that although several precautions were taken, renal blood flow 
was lower in the GA + TEA group compared to the GA + suf group. Plasma concentration of ALD was not 
higher, which indicates that the elevation was not major, however this shows that sufficient hydration is 
necessary when sympaticolysis is enforced in this type of surgery. 
An increase in plasma hormones could also be the result of reduced renal clearance and 
glomerular filtration rate, which is known to be reduced during PP 6. In this study, however, an 
equivalent creatinine and urine output during and after the procedure in both study groups was 
observed. 
Evidence is mounting that patients benefit from diminished surgical trauma and maintained 
immune function after laparoscopic surgery 13,32,33. After laparoscopic surgery, the increase in serum 
CRP values was found to be significantly less pronounced over the first 3 postoperative days, which 
implies a certain benefit for the minimally invasive procedure 13. The effects of epidural blockade with 
local anaesthetics on the pro-inflammatory response to surgery are however controversial 13, 34-36.  In 
the current study, CRP increased considerably after LDN, but epidural anaesthesia could suppress 
this CRP increase. C-reactive protein (CRP) is a liver-derived acute phase protein that serves as a 
non-specific marker of an acute-phase reaction caused by trauma or inflammation. The maximum 
increase of CRP is delayed until day 2 after operation, this delay is caused by protein biosynthesis of the 
acute-phase protein after stimulation. In this study, CRP was indeed at its highest level at the second 
post-operative day. 
To minimize confounding factors that may lead to neuroendocrine stress release, we monitored 
and regulated the depth of anaesthesia and ventilator settings between preset values. BIS (monitoring 
depth of anaesthesia); usage of propofol, PetCO2 and PvCO2 all were comparable between the two study 
groups. 
Our study had some limitations. Statistic analysis was not performed on an intention-to-treat 
basis, conversion to the open technique and insufficient epidural analgesia  were excluded from 
the study. Our mean interest was in the effects of epidural analgesia on stress response during 
LDN. Secondly, although in this study no significant differences for postoperative plasma creatinine 
concentrations were found in the donor and the recipient groups, this significance is under-powered. 
To conclude on this important item in living kidney donor procedures, at least 260 patients would 
be required per group to detect a significant difference with an error of 0.05 and a power of 80%. 
This because with our anaesthesia and fluid regime we already provided  excellent conditions for 
postoperative kidney function. 
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In conclusion, our study shows that thoracic epidural has a beneficial effect on the classic 
neuroendocrine stress response in patients undergoing LDN, and that the postoperative inflammatory 
response was significantly suppressed. If this effect is also beneficial in preventing the moderate 
delayed graft dysfunction in the recipient as seen after LDN needs further research.
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Summary
Chapter 1 provides a general introduction to living laparoscopic donor nephrectomy. 
Laparoscopic donor nephrectomy (LDN) has become popular mainly because of the better quality of life 
compared to open surgery (ODN) after the procudure. Although LDN is beneficial to the donor, there are 
concerns about the transient early delayed graft function compared to the open procedure. Therefore, 
we developed and validated an anaesthesia and peri-operative care protocol in order to prevent this 
delayed graft function. This protocol is discussed. 
Chapter 2 gives a retrospective view of our study population before we started our trial. We 
compared long-term serum creatinine levels in donors and recipients after LDN and ODN. In the 
first week, higher levels of serum creatinine levels are found in recipients of the laparoscopic group. 
Thereafter, serum creatinine levels are comparable for both groups up to 3 years after donation. 
Additionally higher serum creatinine levels are found in the donors after LDN.
In Chapter 3 we prospectively compare three different peri-operative fluid regimes for 
laparoscopic donor nephrectomy. Two study groups are compared to one control group. The two study 
groups received an overnight infusion and a bolus of colloid before induction of anaesthesia and one 
of the groups received another bolus of colloid before the induction of pneumoperitoneum (PP). The 
control group only received intravenous infusion during the operation, conform our old protocol. The 
total amount of fluids used in these three groups is equal, but the timing of administration is different. 
Although this pilot study includes only a small number of patients, we found that overnight infusion 
and a bolus of colloids before PP attenuates the hemodynamic compromise from PP, and that the 
immediate postoperative creatinine clearance is higher in the two study groups compared to the control 
group. Therefore, this optimal fluid regimen is used in the next studies.
Chapter 4 evaluates the mechanisms leading to negative hemodynamic effects during CO2PP. 
These mechanisms can be either the influence of elevated CO2, or compression of the vessels and 
organs due to elevated intra-abdominal pressure (IAP). We found that the decrease in stroke volume 
during CO2PP is due to compression of the intra-abdominal vasculature and/or organs (caused by 
elevated IAP), with subsequent reduction of venous return, and not due to elevated CO2. 
In Chapter 5 we evaluate our newly developed protocol for anaesthesia and fluid management in 
respect to the kidney function of the donor and recipient in LDN vs. ODN. Also, the side effects of this 
new fluid regime are monitored. Hemodynamics, urine output and creatinine clearance are comparable 
in both the LDN and ODN groups up to 2 years after donation. Furthermore, no side effects of the new 
fluid regime are noted.
In Chapter 6 we study the neuroendocrine stress response after ODN and LDN and also 
investigate the effect of the type of anaesthesia on the stress response in both procedures. No 
differences are found between LDN and ODN for norepinephrine, epinephrine, dopamine, renin, 
aldosterone, vasopressin and glucose. However, significantly lower concentrations of epinephrine, 
dopamine, renin and vasopressin are found in favour of the propofol group compared to the isoflurane 
group. 
In Chapter 7 we investigate whether epidural anaesthesia offers any advantages for LDN donors. 
We randomised LDN donors either for general anaesthesia with high dosage of opioids (as used in 
our prior research), or for general anaesthesia with epidural analgesia. Again, we used the same fluid 
protocol and ventilator settings and we titrated anaesthesia to achieve an equal depth of anaesthesia. 
Preservation of kidney function in this patient group is important. Because epidural analgesia with local 
anaesthetics and elevated IAP both (directly or indirectly) influence kidney function, we additionally 
tracked urine output and creatinine clearance during and immediately after the procedure. The epidural 
approach resulted  in a quicker and smoother recovery. Postoperatively these patients are extubated 
110   Summary  –  Samenvatting
CHAPTER
9
faster, have less pain, experience less nausea, and are more comfortable and satisfied than the patients 
with general anaesthesia alone. Additionally, kidney function is comparable in both groups.
In Chapter 8, we use the same study population as in chapter 7, but this time the effect on 
the neuroendocrine stress response is studied. The addition of epidural analgesia results in lower 
norepinephrine and cortisol levels during LDN, and lower CRP levels after the LDN procedure.
 
Samenvatting
Hoofdstuk 1 geeft een algemene introductie over het onderwerp “laparoscopische nierdonatie 
bij leven”. De laparoscopische benadering (LDN) is vooral populair geworden door de betere kwaliteit 
van leven direkt na de operatie, vergeleken met de (klassieke) open benadering (ODN). Hoewel 
LDN voordelen voor de donor oplevert zijn er zorgen over de tijdelijk verminderde functie van het 
transplantaat in vergelijking met ODN. Daarom hebben we een peri-operatief protocol ontwikkeld en 
gevalideerd waarmee deze tijdelijk verminderde nierfunctie na LDN kan worden voorkomen. Dit protocol 
wordt besproken. 
Hoofdstuk 2 geeft een retrospectieve analyse van de studiepopulatie, voor de start van ons 
onderzoek. We vergelijken daarbij de serum kreatinineconcentraties bij donoren en ontvangers na LDN 
en ODN over een langere periode. In de eerste week na LDN werden bij de ontvangers hogere serum 
kreatininewaarden gevonden dan na ODN. Daarna waren deze waarden vergelijkbaar voor LDN en ODN 
tot 3 jaar na de procedure. Ook bij de donoren werden hogere serum kreatininewaarden gevonden na 
LDN.
In hoofdstuk 3 vergelijken we prospectief drie varianten in peri-operatief vloeistofbeleid 
tijdens LDN. Twee studiegroepen worden vergeleken met een controle groep. De twee studiegroepen 
worden behandeld met prehydratie vanaf de avond voor operatie en krijgen voor de inleiding van 
de anesthesie een bolus colloïden toegediend. Eén studiegroep krijgt bovendien een bolus colloïden 
toegediend voordat het pneumoperitoneum (PP) wordt aangelegd. De controlegroep krijgt intraveneus 
vloeistoffen toegediend conform ons oude protocol, namelijk alleen tijdens de ingreep. Het totaal aan 
intraveneus toegediende vloeistoffen is gelijk in alle drie groepen, alleen het tijdstip van toediening van 
de vloeistoffen verschilt. Alhoewel deze pilot studie slechts een klein aantal donoren betreft, kunnen we 
concluderen dat prehydratie in combinatie met een bolus colloïden voordat PP wordt aangelegd, zorgt 
voor minder hemodynamische veranderingen in vergelijking met de controlegroep. Daarnaast is ook 
de post-operatieve kreatinineklaring beter in de twee studiegroepen. We passen vervolgens het meest 
optimale intraveneuze vochtbeleid uit dit onderzoek toe bij de volgende studies.  
Hoofdstuk 4 evalueert de verschillende mechanismen die tot hemodynamisch negatieve effecten 
leiden gedurende CO2PP. De oorzaak daarvan is òf de verhoogde CO2-concentratie òf de mechanische 
druk op de vaten en organen ten gevolge van de verhoogde intra-abdominale druk (IAP). Uit deze 
studie blijkt dat het verminderde slagvolume tijdens CO2PP veroorzaakt wordt door compressie van de 
intra-abdominale vasculatuur en/of organen door de verhoogde IAP, met als gevolg een verminderde 
veneuze return, en niet door een verhoogde CO2-concentratie. 
In hoofdstuk 5 evalueren we ons nieuw ontwikkelde protocol voor anesthesie en intravenues 
vloeistofbeleid bij nierdonatie. De nierfuncties van de nierdonoren en de ontvangers worden vervolgd na 
de ingreep.  Daarnaast worden de eventuele bijwerkingen van dit nieuwe beleid bekeken.  
De hemodynamiek, de urineproductie en de kreatinineklaring tot 2 jaar van de LDN- en ODN-groep zijn 
vergelijkbaar. Er worden geen bijwerkingen geobserveerd in de direct post-operatieve fase.  
In hoofdstuk 6 wordt de stress respons tijdens ODN en LDN vergeleken. Ook wordt gekeken naar 
de vorm van anesthesie. Er blijkt geen verschil te zijn tussen de twee operatietechnieken voor wat betreft 
serumconcentraties noradrenaline, adrenaline, dopamine, renine, aldosteron, vasopressine en glucose. 
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We zien echter wel duidelijk lagere serumconcentraties van adrenaline, dopamine, renine en vasopressine 
in de groep die propofol als anestheticum heeft gehad, in vergelijking met de isoflurane groep. 
In hoofdstuk 7 onderzoeken we of epiduraal analgesie voordelen oplevert voor de donor. Daartoe 
worden LDN donoren gerandomiseerd. De ene groep krijgt algemene anesthesie met hooggedoseerd 
sufentanil (gelijk aan onze vorige studies)  en de andere groep krijgt algemene anesthesie in combinatie 
met epiduraal analgesie. Ook nu weer worden hetzelfde vloeistofbeleid en dezelfde ventilatieinstellingen 
gebruikt en wordt de anesthesie getitreerd op basis van de anesthesiediepte, conform voorgaande 
studies. Aangezien de nierfunctie in deze groep patiënten zo belangrijk is en epiduraal analgesie met 
locaal anesthetica en verhoogde IAP beide (direct of indirect) invloed hebben op de nierdoorbloeding en 
nierfunctie, worden ook de urineproductie en kreatinineklaring tijdens en net na de ingreep gemeten. 
Postoperatief kunnen de patiënten uit de epiduraal groep eerder geëxtubeerd worden en 
is er sprake van minder pijn. Ook is er bij hen in de direct postoperatieve fase minder sprake van 
misselijkheid, ongemak en vermoeidheid dan bij de sufentanil groep en zijn de donoren met de 
epiduraal aanpak meer tevreden. We concluderen dat de post-operatieve fase sneller en aangenamer 
verloopt voor de donoren met epiduraal analgesie, zonder dat de nierfunctie verschil laat zien tussen 
beide studiegroepen.
In hoofdstuk 8, wordt dezelfde studiepopulatie gebruikt als in hoofdstuk 7, echter in dit hoofdstuk 
wordt de stress respons van de sufentanil groep en de epiduraal analgesie groep vergeleken. Het 
toevoegen van epiduraal analgesie leidt tot lagere serumconcentraties noradrenaline en cortisol tijdens 
LDN, en een lagere CRP-concentratie na LDN.
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General discussion 
In our university, M. Lind (2005) and N.F. Kok (2007) have both demonstrated in their thesis that 
laparoscopic kidney donation (LDN) is the procedure of choice, that it is safe for the donor and acceptor, 
and that it offers the best outcome to the donor with regard to quality of life. 
However, Hazebroek et al. (2002) showed already that, in recipients, mean serum creatinine 
was higher after LDN compared with open donor nephrectomy (ODN) shortly after surgery 1. They 
emphasized that this was caused by the pathophysiologic changes due to CO2PP. Our goal was to 
develop a peri-operative care regimen that prevents the delayed graft function as seen after LDN by 
focusing on fluid management and low levels of stress. 
In an effort to combat the cardiovascular, endocrine and renal effects of laparoscopic surgery, 
we first introduced some simple adjustments. The problem of blood pooling in legs und upper trunk 
because of the lateral nephrectomy position, was dealt with by adjustment of position (adapted lateral 
nephrectomy position) and anti-thrombosis stockings 2. In a (unpublished) trial with 6 patients we 
demonstrated that these actions are able to alleviate the reduction in cardiac output with a mean of 
530 ml.min-1. 
To ensure low levels of stress during operation, we used relatively high levels of sufentanil. 
The mean usage of sufentanil until nephrectomy was 124 microg sufentanil for the LDN group and 
103 microg for the ODN group; this latter procedure was shorter in time. To study hemodynamics and 
neuroendocrine stress response changes during operation it is mandatory to standardise the depth of 
anaesthesia. This was achieved by monitoring the depth of anaesthesia with a BIS monitor. The mean 
BIS values were between 40 and 50 units. 
In addition, high intrathoracic pressure reduces venous return and consequently will depress 
the release of atrial natriuretic factor, which is known to interact with AVP. In turn, AVP is known for its 
vasoconstriction and antidiuretic effect. Therefore ventilation settings were directed toward comparable 
(for LDN and ODN) and low peak pressure levels. To achieve this we chose for the pressure-controlled 
ventilation mode, and adequate ventilation was achieved primarily with elevation in ventilation 
frequency and not in ventilation pressure. Although, because of elevated IAP during PP, it is not always 
possible to keep the ventilatory positive pressures at the primary fixed level of 22 kPa, we only had 
to enhance this towards a mean of 25 kPa, with a subsequent PetCO2 mean of 5.3 kPa, for all studies 
together in this thesis. 
As described by London et al. CO2PP results in a relatively hypovolemic state leading to 
decreased intra-abdominal blood flow and urine output 3.  The pressure exerted on the inferior vena 
cava during pneumoperitoneum (PP) in volume-depleted animals results in partial caval compression, 
thereby decreasing preload and stroke volume 4. In an attempt to ameliorate the decrease in venous 
return and urine output, vigorous hydration intra-operatively was advocated 3,5. This view has enforced 
a widely used high-volume fluid regimen for the LDN procedures, up to 2 L.h-1 of crystalloids 6-10, 
but this has never been investigated in a prospective study in humans. However, we believed that 
volume loading after establishment of PP is too late in order to counterbalance the pathophysiologic 
compromise of CO2PP during living kidney procurement. We emphasized that the fluid regime should 
focus on prophylactic volume expansion. The relative hypovolemia induced by position and elevated 
IAP due to PP should be compensated before these are established, thereafter the fluid load can be 
restricted. This is shown in chapter 3 in which we found that prehydration with crystalloids and colloids 
before installation of PP resulted in less hemodynamic and renal function compromise. 
To draw the conclusion that the reduced incidence of delayed graft function following the LDN 
procedure was resolved as result of our new peri-operative regimen is tempting. However, several 
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confounding factors should be considered. The retrospective study from chapter 2 comparing kidney 
function after the ODN and LDN procedure with our previous anaesthetic peri-operative regiem and the 
prospective study from chapter 5 comparing kidney function after the ODN and LDN procedure with 
our new anaesthetic peri-operative regiem are not completely comparable. 
The experience of the surgeons with the LDN procedure has improved over the years. Besides 
the surgical approach for ODN has changed; the formerly used ODN procedure was done with the 
traditional lumbotomy approach, the ODN procedure in the prospective trial was performed with the 
mini-incision technique, developed in our clinic (the Erasmus MC muscle-split technique) 11. 
In addition, the donor population has changed; less healthy people are willing to donate a kidney and 
inclusion criteria seem to have slightly adapted. In our prospective studies 76% of the donors were 
classified as ASA I in the LDN group, compared to 82% in the retrospective study (The American 
Society Anaesthesiologists, ASA Class II, beholds patients with mild systemic diseases i.e. hypertension, 
smoking, thyroid disease and others). Also, the mean preoperative serum creatinine of the donors and 
recipients has increased over the years. In addition, the mean percentage of unrelated living donations 
has increased from 12% to 27%, which all may have had an impact on the graft function in the recipient. 
The recipients can be divided into three groups; the peritoneal dialysis group, the hemodialysis group 
and the pre-dialysis group. However, we do not have an overview of the hemodynamic response 
to anaesthesia of these three groups. It seems that the hemodialysis patients react with more 
hypotension and have lower stroke volume after induction of anaesthesia than the patients from the 
other two groups. This could have a direct effect on the graft function of the newly received kidney 
in the recipient. We will use all the collected data of the recipients to deal with this issue in a future 
retrospective study.  
It is arguable as to whether the donor groups were comparable in view of the chosen kidney for 
donation. The two kidneys from the donor can differ in function, so the choice of which kidney is 
harvested for donation can bias the outcome in graft function outcome. An MAG3 scan provides 
the distribution of the function from the two kidneys of the donor; however, in our institution only 
a minority of the donors was scanned and therefore we were not able to include this factor in our 
comparison.
Finally, in this thesis we did not take into account the progression over the years in the field of the 
nephrologists. The improvement in immunostatic therapy after kidney transplantation for the recipient 
must certainly have had a considerable influence on the outcome of renal graft function. Because 
the recipients are a very inhomogeneous group (different ASA classification, different morbidity, and 
different forms of dialysis) and because over the years postoperative treatment by the nephrologists 
has changed, comparing renal function in the acceptors is bound to be a subject to these confounding 
factors. Therefore we focused on the postoperative renal function outcome of the donors; this was 
based on the assumption that if the anaesthesia regimen matters to the donated kidney then it also 
matters for the kidney that was donated. 
We cannot rule out that above mentioned improvements over the years have had their impact on the 
difference in postoperative kidney function between LDN and ODN. 
In most studies postoperative pain is significantly reduced by the laparoscopic approach as  
compared with open techniques. However, in the immediate postoperative period, pain in the 
laparoscopic patient, which is mainly identified as subcostal pain or shoulder tip pain, can be as 
severe as after laparotomy, 12-14. In their prospective study comparing laparoscopy with laparotomy 
with comparable peri-operative pain management, Ekstein et al. showed that the pain VAS of the 
laparotomy patients was 4.1 compared with 6.1 in the laparoscopy patients12. We confirmed in Chapter 
7 that the laparoscopic approach in the direct postoperative period can be rather painful; in spite 
of administration of high dosage of sufentanil during the LDN procedure, the patients indicated one 
hour after extubation a VAS score of 4.5 for pain. Thoracic epidural analgesia (TEA) is known for its 
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favourable profile for postoperative outcome. Moreover, in an unpublished pilot study of 5 patients, 
we found that epidural administered low dosage of morphine was effective in reducing the typical 
postoperative laparoscopic pain. 
Because epidural administered local anaesthetics induce a sympathicolysis in the target area, 
the kidney will partly loose its ability to autoregulate its blood flow. Therefore, if epidural anaesthesia 
is chosen extra care should be given to the fluid balance. With the novel fluid regime used in this study 
no differences in urine output or creatinine clearance are observed in the donor patient. Also the 
renal function of the recipient, monitored up to one month after the transplantation, did not show any 
differences between the sufentanil and epidural group. Our epidural failure rate was 15%; one can argue, 
however, that this failure rate is too high for the benefit which epidural analgesia is producing. 
Conclusions and Future perspectives
Adequate fluid loading before installation of PP, together with prevention of blood pooling with 
anti-thrombosis stockings and adjustment of the position, adequate ventilation with the aim to minimize 
elevated intrathoracic pressures, high dose of sufentanil and adequate depth of anaesthesia resulted 
in the prevention of the hemodynamic and renal compromise encountered due to elevated IAP, during 
LDN. Moreover, the differences in stress response between ODN and LDN have disappeared with this 
regimen. The use of propofol anaesthesia and the addition of epidural analgesia further reduced the 
stress response and provided a faster and qualitatively better direct postoperative recovery.
In conclusion, the work presented in this thesis shows that the anaesthetist is able to improve  
the outcome for the donor patient, as well as for the donor kidney.
Future directions include addressing the tendency of accepting more donors with morbidity 
(such as older age, hypertension and obesity), and increasing the number of live kidney donors 
without compromising safety to the donors or the graft. The complex pathophysiological state induced 
by CO2PP, i.e. an increase in afterload with a drop in cardiac output, and reduced renal blood flow 
was tackled with our new anaesthesia regime. However, we did not prove that these precautions 
were sufficient for the increasing number of donors with minor diseases. Struther emphasized that 
pharmacological treatment could prevent the negative pathophysiological reaction towards PP 15. 
Studying pharmacological options (like selective renin and AVP inhibitors) could result in a protective 
treatment as well as a further insight in the pathophysiologic procedures during elevated IAP. As yet,  
no one has explored peri-operative use of these drugs as a means to prevent the harmful cardiovascular 
and renal effects of positive-pressure PP. 
The main issue of this thesis was reduction of delayed graft function due to CO2PP during LDN 
compared to ODN. To confirm that our newly developed anaesthesia regime does indeed eliminate the 
delayed graft function after the LDN procedure, a sufficiently powered multi-center trial should be 
initiated. However, most of the transplantation centers have already adapted the LDN procedure as the 
favorable approach for living donor nephrectomy. 
Until now we proved with indirect measurements (i.e. stroke volume, urine output, creatinine 
clearance, hormones) that we might have reduced the compromised RBF associated with LDN.  In 
our next study we will measure RBF and GFR with more advanced methods like para-aminohippurate 
clearance and inulin clearance. We will record the changes in RBF and GFR when PP is installed, and 
probably confirm with this direct method that our peri-operative care regime does indeed have a 
positive effect on RBF during elevated IAP. 
The hand assistant approach for donor nephrectomy is now being adapted in our hospital; this 
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procedure also includes CO2PP, but is a faster procedure compared with LDN.  A new trial will be started 
in the near future for comparison of the hand assitant technique with LDN. Additionally we will study 
the effect of our anaesthesia regimen on RBF during these two procedures. 
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Abbreviations
Acc Acceleration
ADH Anti Diuretic Hormone
ADL Aldosteron
ASA American Society of Anaesthesiologists 
ATN Acute Tubular Necrosis
AVP  arginin Vasopressin
BIS Bispectral index
CO Cardiac Output
CO2PP  CO2 Pneumoperitoneum
DGF Delayed Graft function
E Epinephrine
ESRD End stage renal disease
GFR  Glomerular Filtration Rate
IAP  Intra Abdominal Pressure
IBW Ideal Body Weight
IPPV inspiratory positive pressure ventilation
LDN Laparoscopic Donor Nephrectomy
LVET Left Ventricular Ejection Time
MAP Mean Arterial Pressure
NE Nonepinephrine
ODN  Open Donor Nephrectomy
PCV Pressure controlled ventilation
PEEP Positive end exspiratory pressure
PIP Positive inspiratory pressure
PP Pneumoperitoneum
RAAS   Renin-Anginotensin-Aldosteron System
RBF Renal Blood Flow
REN Renin
SV  Stroke Volume
SVR  Systemic Vascular Resistance
TEA Thoracic Epidural Analgesia
TOF Train of Four
VCO2 CO2 production per minute
VO2 O2 production per minute
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Nawoord
Narcose beschouw ik als een beademde dood, een artificiële dood, een verzwakt en vervalst beeld 
van de eeuwigheid. Voor een patiënt is niets leger dan een narcose. Niets is er alles, er wordt niet geleden 
en de wetten van de tijd zijn slechts spaties tussen woorden van leegheid. Een heerlijkheid. Want als de dood 
is als een narcose, dan is er niets om bang voor te zijn. Toch? En mocht er meer zijn, dan is dat dus mooi 
meegenomen. En dit alles - of moet ik zeggen ‘niets’ - vindt plaats in de gevaarlijkste ruimte op aarde, de 
OK, waar medisch specialisten goden zijn, of zich als zodanig gedragen.
Mijn naam is André Bek. Ik beschouw mezelf, zonder enige valse bescheidenheid, na vier niertransplantaties 
van levende donoren binnen 20 jaar, als ‘gepromoveerd’ ontvanger. Over mijn leven, belevenissen en 
zieleroerselen schreef ik een boek: ‘Dansen in het zand - Een leven in geschonken tijd’. Ingrid Mertens zur 
Borg speelt daarin een essentiële rol. Deze ‘godin’ hielp mijn dierbare donor en mij, nagenoeg vrij van lijden, 
over de kloof die de werelden van onbenoembaar gezamenlijk sukkelen en gezamenlijke wedergeboorte van 
elkaar scheidt. 
‘Het is het laatste wat ik me van haar herinner. Er brandt iets in mijn aderen, het stijgt vanuit mijn linkerarm 
zwaar naar mijn hoofd. Vormen vervagen. Gedaanten verdwijnen in een dikke mist. Stilte overstemt ieder 
geluid.
Het licht gaat uit. Een val in een volkomen tijdloos, droomloos gat. En toen was er niets meer. Geen 
waarnemingen, geen gedachten, geen verwachtingen, geen herinneringen, geen dromen, geen duisternis, 
geen licht, geen pijn, geen zorgen, geen ziekte, geen leegte, geen José, geen ik. Helemaal niets. De totale 
afwezigheid van iets. Mijn bewustzijn en zeggenschap zijn niet meer.’ (citaat uit: ‘Dansen in het zand’)
Later ontmoette ik niet zozeer de gewaardeerde anesthesioloog dokter Mertens zur Borg, maar Ingrid, een 
enthousiaste lezeres van ‘Dansen in het zand’, de kwetsbare mens achter de dokter. Een lieve en gedreven 
vrouw. Mijn boek sloeg een brug tussen betrokkenheid en professionele distantie. Een zeldzaam genoegen. 
De afgelopen 20 jaar ben ik als niertransplantatiepatiënt getuige geweest van nauwelijks bij te 
houden ontwikkelingen op de gebieden van anesthesie, medicatie, operatietechnieken en verpleging. De 
synergie van deze deelontwikkelingen heeft de drempel voor nierdonatie bij leven vanuit medisch-ethisch 
oogpunt en vanuit het (potentiële) donorenperspectief verlaagd. Het is tot op heden ook verreweg de 
beste niervervangende therapie. De resultaten van transplantaties met een nier van een levende donor 
zijn duidelijk beter dan die waarbij een postmortale nier wordt getransplanteerd en in alle opzichten 
onvergelijkbaar met de zwaar belastende dialyse. Bovendien is het de enige mogelijkheid om pre-emptief te 
transplanteren.
Zelfs bij aanname van een rechtvaardiger geen-bezwaarsysteem, een utopie vrees ik, zal er schaarste aan 
organen blijven bestaan. Ook dan zullen er patiënten op de wachtlijst sterven voordat ze een levensreddend 
orgaan ontvangen. Nierdonatie bij leven is om al die redenen een niet meer weg te denken fenomeen. 
Het is een moedige daad, de nierdonor stelt zichzelf bloot aan risico’s en is een periode onttrokken aan 
het maatschappelijke leven. Des te meer verdienen deze donoren uitmuntende zorg en het profijt van 
voortschrijdend medisch inzicht. 
De laparoscopische operatietechniek gecombineerd met epidurale anesthesie is zo’n meer dan fantastische 
vooruitgang. Zowel nierdonoren als ontvangers zijn er in meerdere opzichten direct bij gebaat. Het voordeel 
van een beduidend minder belastende ingreep voor de donor en het overbrengen van een optimaal 
werkende donornier naar de ontvanger is onbetwistbaar. Het verlagen van de drempel om bij leven een 
nier te doneren levert zelfs indirect een positief effect op de wachtlijst. Ik complimenteer en feliciteer Ingrid 
met dit geweldige resultaat, waarbij ze haar eigen ontwikkeling in dienst heeft gesteld van de lijdende 
medemens. Een ware arts, een arts naar mijn hart en donornier. 
  
Door André Bek, Auteur van ‘Dansen In Het Zand - Een Leven In Geschonken Tijd’
Barendrecht, februari 2008. 
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Anaesthesia and 
peri-operative Care for
Laparoscopic Donor 
Nephrectomy
Ingrid Mertens zur Borg
Adequate fl uid loading before 
installation of Pneumoperithoneum, 
together with prevention of blood 
pooling with anti-thrombosis stockings 
and adjustment of the position, 
adequate ventilation with the aim 
to minimize elevated intrathoracic 
pressures, high dose of sufentanil and 
adequate depth of anaesthesia results 
in the prevention of the hemodynamic 
and renal compromise encountered 
due to elevated intra-abdominal 
pressure, during laparoscopic donor 
nephrectomy. 
Moreover, the differences in stress 
response between open donor 
nephrectomy and laparoscopic donor 
nephrectomy have disappeared with 
this regimen. The use of propofol 
anaesthesia and the addition of 
epidural analgesia further reduced 
the stress response and provided a 
faster and qualitatively better direct 
postoperative recovery.
In conclusion, the work presented in 
this thesis shows that the anaesthetist 
is able to improve the outcome for the 
donor patient, as well as for the donor 
kidney.
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